{"items": "165", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma", "url": "https://www.globenewswire.com/news-release/2024/12/30/3002594/25619/en/Chimerix-Submits-Dordaviprone-New-Drug-Application-for-Accelerated-Approval-to-U-S-FDA-for-Patients-with-Recurrent-H3-K27M-Mutant-Diffuse-Glioma.html", "time_published": "20241230T120000", "authors": ["Chimerix", "Inc."], "summary": "Secures Access of Up To $30 Million to Support Potential Launch Through Silicon Valley Bank Credit Facility Secures Access of Up To $30 Million to Support Potential Launch Through Silicon Valley Bank Credit Facility ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}], "overall_sentiment_score": 0.236353, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.404925", "ticker_sentiment_score": "0.308529", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings - AutoZone  ( NYSE:AZO ) , Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/news/earnings/24/12/42421738/s-autozone-posts-downbeat-earnings", "time_published": "20241210T190050", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling by around 0.1% on Tuesday. The Dow traded down 0.02% to 44,393.25 while the NASDAQ rose 0.03% to 19,743.54. The S&P 500 also fell, dropping, 0.06% to 6,049.44. Communication services shares jumped by 2.3% on Tuesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/10/Wall-Street_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.094697, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRM", "relevance_score": "0.176502", "ticker_sentiment_score": "0.030699", "ticker_sentiment_label": "Neutral"}, {"ticker": "YEXT", "relevance_score": "0.176502", "ticker_sentiment_score": "0.235474", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CPIX", "relevance_score": "0.176502", "ticker_sentiment_score": "0.351406", "ticker_sentiment_label": "Bullish"}, {"ticker": "AZO", "relevance_score": "0.176502", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.176502", "ticker_sentiment_score": "0.224262", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRVO", "relevance_score": "0.176502", "ticker_sentiment_score": "-0.051669", "ticker_sentiment_label": "Neutral"}]}, {"title": "Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings - Cumberland  ( NASDAQ:CPIX ) , Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/24/12/42419990/gold-gains-over-1-ollies-bargain-outlet-shares-jump-after-q3-earnings", "time_published": "20241210T173756", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded up 0.02% to 44,412.05 while the NASDAQ rose 0.25% to 19,786.14. The S&P 500 also rose, gaining, 0.07% to 6,057.30. Communication services shares jumped by 2.5% ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/10/Turning-to-Gold.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.179798, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MRM", "relevance_score": "0.169081", "ticker_sentiment_score": "0.029783", "ticker_sentiment_label": "Neutral"}, {"ticker": "YEXT", "relevance_score": "0.169081", "ticker_sentiment_score": "0.2288", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CPIX", "relevance_score": "0.169081", "ticker_sentiment_score": "0.341998", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.169081", "ticker_sentiment_score": "0.21788", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRVO", "relevance_score": "0.169081", "ticker_sentiment_score": "-0.050126", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLLI", "relevance_score": "0.169081", "ticker_sentiment_score": "0.198732", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Dow Falls 150 Points; Oracle Posts Downbeat Results - Biora Therapeutics  ( NASDAQ:BIOR ) , Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/24/12/42415162/dow-falls-150-points-oracle-posts-downbeat-results", "time_published": "20241210T144924", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed this morning, with the Dow Jones index falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.36% to 44,242.81 while the NASDAQ rose 0.43% to 19,820.91. The S&P 500 also fell, dropping, 0.01% to 6,052.43.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/10/wall-street-ai16.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.111166, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRM", "relevance_score": "0.179121", "ticker_sentiment_score": "0.031026", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORCL", "relevance_score": "0.179121", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPIX", "relevance_score": "0.179121", "ticker_sentiment_score": "0.354753", "ticker_sentiment_label": "Bullish"}, {"ticker": "BIOR", "relevance_score": "0.179121", "ticker_sentiment_score": "0.306546", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.179121", "ticker_sentiment_score": "0.226542", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRVO", "relevance_score": "0.179121", "ticker_sentiment_score": "-0.052219", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cancer-Focused Chimerix Stock Is Up Than 100% On Tuesday - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/general/biotech/24/12/42414929/why-is-cancer-focused-chimerix-stock-trading-higher-on-tuesday", "time_published": "20241210T143934", "authors": ["Vandana Singh"], "summary": "On Monday, Chimerix CMRX announced that, following extensive dialogue with the FDA, the company plans to submit a complete New Drug Application ( NDA ) seeking accelerated approval for dordaviprone for recurrent H3 K27M-mutant diffuse glioma in the U.S. before year-end.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/10/CMRX.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.2716, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.543004", "ticker_sentiment_score": "0.392807", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - C3.ai  ( NYSE:AI ) , Asset Entities  ( NASDAQ:ASST ) ", "url": "https://www.benzinga.com/24/12/42408189/why-c3-ai-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket", "time_published": "20241210T110529", "authors": ["Avi Kapoor"], "summary": "Shares of C3.ai, Inc. AI rose sharply in today's pre-market trading session after the company reported better-than-expected second-quarter financial results. C3.ai reported quarterly losses of six cents per share, which beat the analyst consensus estimate for losses of 16 cents.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/10/C3-ai-signage.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.897321"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.070299, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "YEXT", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.251212", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CPIX", "relevance_score": "0.162802", "ticker_sentiment_score": "0.145645", "ticker_sentiment_label": "Neutral"}, {"ticker": "GELS", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.159052", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MNTS", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.332846", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PCSA", "relevance_score": "0.162802", "ticker_sentiment_score": "0.209914", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RADX", "relevance_score": "0.162802", "ticker_sentiment_score": "0.024271", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.162802", "ticker_sentiment_score": "0.209914", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VEEE", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.016187", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRM", "relevance_score": "0.162802", "ticker_sentiment_score": "0.062562", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASST", "relevance_score": "0.162802", "ticker_sentiment_score": "0.148024", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.162802", "ticker_sentiment_score": "0.219259", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TNMG", "relevance_score": "0.162802", "ticker_sentiment_score": "0.326325", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LPTH", "relevance_score": "0.162802", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUIZ", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.205138", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NBTX", "relevance_score": "0.242084", "ticker_sentiment_score": "-0.267384", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DUO", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.15369", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End", "url": "https://www.globenewswire.com/news-release/2024/12/09/2994081/25619/en/Chimerix-to-Submit-Dordaviprone-for-Accelerated-Approval-to-U-S-FDA-for-Patients-with-Recurrent-H3-K27M-Mutant-Diffuse-Glioma-Before-Year-End.html", "time_published": "20241209T210100", "authors": ["Inc.", "Chimerix"], "summary": "Potential Approval in Q3 2025 in Recurrent H3 K27M-Mutant Diffuse Glioma ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.210454, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.332758", "ticker_sentiment_score": "0.191165", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/24/12/g42373079/chimerix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4", "time_published": "20241206T210100", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., Dec. 06, 2024 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, today announced that on December 2, 2024, the Compensation Committee of Chimerix's Board of Directors granted inducement awards to three new employees of non-statutory stock options to purchase up to a total of 385,000 shares of ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.28113, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.419153", "ticker_sentiment_score": "0.323955", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/12/06/2993259/25619/en/Chimerix-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20241206T210100", "authors": ["Chimerix", "Inc."], "summary": "DURHAM, N.C., Dec. 06, 2024 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , today announced that on December 2, 2024, the Compensation Committee of Chimerix's Board of Directors granted inducement awards to three new employees of non-statutory stock options to purchase up to a total of 385,000 ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.299301, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.340915", "ticker_sentiment_score": "0.301819", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting", "url": "https://www.globenewswire.com/news-release/2024/11/11/2978198/25619/en/Chimerix-Announces-Updated-Phase-2-Response-Assessment-of-Dordaviprone-in-Recurrent-H3-K27M-Glioma-at-the-2024-SNO-Meeting.html", "time_published": "20241111T120000", "authors": ["Inc.", "Chimerix"], "summary": "DURHAM, N.C., Nov. 11, 2024 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ: CMRX ) , a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced upcoming presentations at the 2024 Society for ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.076495, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.236396", "ticker_sentiment_score": "0.061832", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( CMRX )  Reports Q3 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2366103/chimerix-cmrx-reports-q3-loss-lags-revenue-estimates", "time_published": "20241107T133505", "authors": ["Zacks Equity Research"], "summary": "Chimerix (CMRX) delivered earnings and revenue surprises of -8.33% and 97.94%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default12.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.096156, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IFRX", "relevance_score": "0.140485", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.404563", "ticker_sentiment_score": "0.071437", "ticker_sentiment_label": "Neutral"}]}, {"title": "UniQure  ( QURE )  Reports Q3 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2364139/uniqure-qure-reports-q3-loss-lags-revenue-estimates", "time_published": "20241105T133003", "authors": ["Zacks Equity Research"], "summary": "uniQure (QURE) delivered earnings and revenue surprises of 18.75% and 16.32%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default97.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.091675, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.139265", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024 - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/24/11/g41679872/chimerix-to-report-third-quarter-2024-financial-results-and-provide-an-operational-update-on-novem", "time_published": "20241101T110000", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., Nov. 01, 2024 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.157961, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.598621", "ticker_sentiment_score": "0.194265", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/10/18/2965738/25619/en/Chimerix-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20241018T203100", "authors": ["Inc.", "Chimerix"], "summary": "DURHAM, N.C., Oct. 18, 2024 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , today announced that on October 16, 2024, the Compensation Committee of Chimerix's Board of Directors granted an inducement award to a new employee of non-statutory stock options to purchase up to a total of 130,000 ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.305846, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.345674", "ticker_sentiment_score": "0.318323", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/08/30/2938704/25619/en/Chimerix-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20240830T200500", "authors": ["Inc.", "Chimerix"], "summary": "DURHAM, N.C., Aug. 30, 2024 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , today announced that on August 20, 2024, the Compensation Committee of Chimerix's Board of Directors granted an inducement award to a new employee of non-statutory stock options to purchase up to a total of 150,000 ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.305846, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.345674", "ticker_sentiment_score": "0.318323", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix  ( CMRX )  Reports Q2 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2321090/chimerix-cmrx-reports-q2-loss-misses-revenue-estimates", "time_published": "20240813T121504", "authors": ["Zacks Equity Research"], "summary": "Chimerix (CMRX) delivered earnings and revenue surprises of 0% and 89.76%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default133.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999483"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.096196, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PGEN", "relevance_score": "0.212425", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.410059", "ticker_sentiment_score": "0.074902", "ticker_sentiment_label": "Neutral"}]}, {"title": "Elanco Animal Health Incorporated  ( ELAN )  Q2 Earnings and Revenues Top Estimates", "url": "https://www.zacks.com/stock/news/2318831/elanco-animal-health-incorporated-elan-q2-earnings-and-revenues-top-estimates", "time_published": "20240808T113503", "authors": ["Zacks Equity Research"], "summary": "Elanco Animal Health (ELAN) delivered earnings and revenue surprises of 25% and 3.23%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default252.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.139581, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ELAN", "relevance_score": "0.389889", "ticker_sentiment_score": "0.106787", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.134968", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rapid Advancements of Innovative Antiviral - COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market - Nanoviricides  ( AMEX:NNVC ) , Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/24/08/g40188357/rapid-advancements-of-innovative-antiviral-covid-19-drugs-generating-major-growth-in-global-antivi", "time_published": "20240806T124500", "authors": ["Globe Newswire"], "summary": "PALM BEACH, Fla., Aug. 06, 2024 ( GLOBE NEWSWIRE ) -- FinancialNewsMedia.com News Commentary - The demand for antiviral drugs has been increasing globally due to the growing prevalence of viral diseases.", "banner_image": "https://ml.globenewswire.com/media/f326183f-8829-42af-8851-525b1d7503ed/small/finacialnews-logo-final-01-2-png.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.993856"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.186417, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCRX", "relevance_score": "0.079195", "ticker_sentiment_score": "0.126448", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.019829", "ticker_sentiment_score": "-0.067186", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERU", "relevance_score": "0.098903", "ticker_sentiment_score": "0.134978", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.079195", "ticker_sentiment_score": "0.129236", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.098903", "ticker_sentiment_score": "0.118779", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/07/05/2909182/25619/en/Chimerix-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20240705T200500", "authors": ["Chimerix", "Inc."], "summary": "DURHAM, N.C., July 05, 2024 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , today announced that on July 1, 2024, the Compensation Committee of Chimerix's Board of Directors granted inducement awards to two new employees of non-statutory stock options to purchase up to a total of 120,000 shares ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.297398, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.371523", "ticker_sentiment_score": "0.316493", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix  ( NASDAQ:CMRX )  Lifted to Hold at StockNews.com", "url": "https://www.defenseworld.net/2024/06/08/chimerix-nasdaqcmrx-lifted-to-hold-at-stocknews-com.html", "time_published": "20240609T103559", "authors": ["Defense World Staff"], "summary": "Chimerix ( NASDAQ:CMRX - Get Free Report ) was upgraded by investment analysts at StockNews.com from a \"sell\" rating to a \"hold\" rating in a report released on Saturday.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo-1200x675.png?v=20221220142845", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.947132"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.243428, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.903334", "ticker_sentiment_score": "0.412261", "ticker_sentiment_label": "Bullish"}]}, {"title": "Chimerix  ( NASDAQ:CMRX )  Upgraded to Hold at StockNews.com", "url": "https://www.defenseworld.net/2024/05/30/chimerix-nasdaqcmrx-upgraded-to-hold-at-stocknews-com.html", "time_published": "20240530T080249", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Chimerix ( NASDAQ:CMRX - Free Report ) from a sell rating to a hold rating in a research note published on Wednesday. A number of other research analysts have also recently issued reports on the stock.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo.png?v=20221220142845", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.947132"}], "overall_sentiment_score": 0.281655, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.077094", "ticker_sentiment_score": "0.072776", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.853391", "ticker_sentiment_score": "0.462685", "ticker_sentiment_label": "Bullish"}]}, {"title": "Chimerix  ( NASDAQ:CMRX )  Cut to Sell at StockNews.com", "url": "https://www.defenseworld.net/2024/05/21/chimerix-nasdaqcmrx-cut-to-sell-at-stocknews-com.html", "time_published": "20240521T071844", "authors": ["Defense World Staff"], "summary": "Chimerix ( NASDAQ:CMRX - Get Free Report ) was downgraded by investment analysts at StockNews.com from a \"hold\" rating to a \"sell\" rating in a report issued on Tuesday.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo-1200x675.png?v=20221220142845", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.266011, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.884459", "ticker_sentiment_score": "0.444164", "ticker_sentiment_label": "Bullish"}]}, {"title": "Chimerix  ( NASDAQ:CMRX )  Rating Increased to Hold at StockNews.com", "url": "https://www.defenseworld.net/2024/05/15/chimerix-nasdaqcmrx-rating-increased-to-hold-at-stocknews-com.html", "time_published": "20240515T083643", "authors": ["Defense World Staff"], "summary": "Chimerix ( NASDAQ:CMRX - Get Free Report ) was upgraded by stock analysts at StockNews.com from a \"sell\" rating to a \"hold\" rating in a research note issued to investors on Monday. Other equities research analysts also recently issued reports about the stock.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo-1200x675.png?v=20221220142845", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}, {"topic": "Earnings", "relevance_score": "0.947132"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.205073, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.07446", "ticker_sentiment_score": "0.044902", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.148273", "ticker_sentiment_score": "0.18336", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JACK", "relevance_score": "0.07446", "ticker_sentiment_score": "0.044902", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.839046", "ticker_sentiment_score": "0.343308", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Downgrades Chimerix  ( NASDAQ:CMRX )  to Sell", "url": "https://www.defenseworld.net/2024/05/06/stocknews-com-downgrades-chimerix-nasdaqcmrx-to-sell.html", "time_published": "20240506T105456", "authors": ["Defense World Staff"], "summary": "StockNews.com cut shares of Chimerix ( NASDAQ:CMRX - Free Report ) from a hold rating to a sell rating in a research report report published on Friday morning. CMRX has been the subject of a number of other research reports.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo.png?v=20221220142845", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.184938, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EAT", "relevance_score": "0.078354", "ticker_sentiment_score": "0.022593", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.905502", "ticker_sentiment_score": "0.318428", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024", "url": "https://www.globenewswire.com/news-release/2024/04/24/2868440/25619/en/Chimerix-to-Report-First-Quarter-2024-Financial-Results-and-Provide-an-Operational-Update-on-May-1-2024.html", "time_published": "20240424T110000", "authors": ["Inc.", "Chimerix"], "summary": "DURHAM, N.C., April 24, 2024 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.122692, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.613172", "ticker_sentiment_score": "0.183377", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix Appoints Marc D. Kozin to Board of Directors - UFP Techs  ( NASDAQ:UFPT ) , Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/24/03/g37866028/chimerix-appoints-marc-d-kozin-to-board-of-directors", "time_published": "20240321T110000", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., March 21, 2024 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.317057, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "UFPT", "relevance_score": "0.227007", "ticker_sentiment_score": "0.148388", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.751437", "ticker_sentiment_score": "0.587396", "ticker_sentiment_label": "Bullish"}]}, {"title": "Chimerix  ( NASDAQ:CMRX )  Upgraded at StockNews.com", "url": "https://www.defenseworld.net/2024/03/06/chimerix-nasdaqcmrx-upgraded-at-stocknews-com.html", "time_published": "20240306T065243", "authors": ["Defense World Staff"], "summary": "Chimerix ( NASDAQ:CMRX - Get Free Report ) was upgraded by StockNews.com from a \"sell\" rating to a \"hold\" rating in a research report issued to clients and investors on Monday. Other research analysts also recently issued research reports about the company.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo-1200x675.png?v=20221220142845", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.243387, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GTLB", "relevance_score": "0.076602", "ticker_sentiment_score": "0.037213", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.152499", "ticker_sentiment_score": "0.194967", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BA", "relevance_score": "0.076602", "ticker_sentiment_score": "0.037213", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.751437", "ticker_sentiment_score": "0.388108", "ticker_sentiment_label": "Bullish"}]}, {"title": "Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/24/02/g37388833/chimerix-reports-fourth-quarter-and-year-end-2023-financial-results-and-provides-operational-updat", "time_published": "20240229T120000", "authors": ["Globe Newswire"], "summary": "- ONC201 ACTION Study Progressing; Reiterate Interim OS Data Expected in 2025, Final OS Data Expected in 2026 - - Phase 2 ONC201 Data Published in Peer-Reviewed Journal of Clinical Oncology - - $204 Million in Cash and Equivalents at December 31, 2023 - - Conference Call at 8:30 a.m. ET Today -", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.162965, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.475461", "ticker_sentiment_score": "0.258034", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBS", "relevance_score": "0.036255", "ticker_sentiment_score": "0.106964", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix to Present at TD Cowen 44th Annual Health Care Conference - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/24/02/g37331286/chimerix-to-present-at-td-cowen-44th-annual-health-care-conference", "time_published": "20240227T120000", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., Feb. 27, 2024 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Andriole, Chief Executive Officer, will participate in a ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.0954, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.656549", "ticker_sentiment_score": "0.209494", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024", "url": "https://www.globenewswire.com/news-release/2024/02/22/2833506/25619/en/Chimerix-to-Report-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provide-an-Operational-Update-on-February-29-2024.html", "time_published": "20240222T120000", "authors": ["Chimerix", "Inc."], "summary": "DURHAM, N.C., Feb. 22, 2024 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.120311, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.608634", "ticker_sentiment_score": "0.179205", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "atai Life Sciences Appoints Anne Johnson as Chief Financial Officer - ATAI Life Sciences  ( NASDAQ:ATAI ) ", "url": "https://www.benzinga.com/pressreleases/24/02/g36968180/atai-life-sciences-appoints-anne-johnson-as-chief-financial-officer", "time_published": "20240206T220031", "authors": ["Globe Newswire"], "summary": "NEW YORK and BERLIN, Feb. 06, 2024 ( GLOBE NEWSWIRE ) -- atai Life Sciences ATAI ( \"atai\" or \"Company\" ) today announced that Anne Johnson, the Company's interim Chief Financial Officer since October 2023 and Chief Accounting Officer since August 2022, has been named Chief Financial Officer ( ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.795202"}], "overall_sentiment_score": 0.263966, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WMGTF", "relevance_score": "0.053629", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.053629", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "atai Life Sciences Appoints Anne Johnson as Chief Financial Officer", "url": "https://www.globenewswire.com/news-release/2024/02/06/2824780/0/en/atai-Life-Sciences-Appoints-Anne-Johnson-as-Chief-Financial-Officer.html", "time_published": "20240206T220000", "authors": ["Atai Life Sciences AG"], "summary": "NEW YORK and BERLIN, Feb. 06, 2024 ( GLOBE NEWSWIRE ) -- atai Life Sciences ( NASDAQ: ATAI ) ( \"atai\" or \"Company\" ) today announced that Anne Johnson, the Company's interim Chief Financial Officer since October 2023 and Chief Accounting Officer since August 2022, has been named Chief Financial ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/5456f837-f0e0-4c61-a132-08f88754e282", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.682689"}], "overall_sentiment_score": 0.277494, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WMGTF", "relevance_score": "0.055236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.055236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Appoints Lisa Decker to Board of Directors - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36424558/chimerix-appoints-lisa-decker-to-board-of-directors", "time_published": "20231229T120000", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., Dec. 29, 2023 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced Lisa Decker, Chief Business Officer at IGM Biosciences, has been ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.178239, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IGMS", "relevance_score": "0.238133", "ticker_sentiment_score": "0.016376", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCEL", "relevance_score": "0.120431", "ticker_sentiment_score": "0.01262", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.870266", "ticker_sentiment_score": "0.44395", "ticker_sentiment_label": "Bullish"}, {"ticker": "NKTR", "relevance_score": "0.120431", "ticker_sentiment_score": "0.01262", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Appoints Lisa Decker to Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/12/29/2802020/25619/en/Chimerix-Appoints-Lisa-Decker-to-Board-of-Directors.html", "time_published": "20231229T120000", "authors": ["Chimerix", "Inc."], "summary": "Seasoned Industry Executive Brings More Than 25 Years of Leadership and Business Development Experience Seasoned Industry Executive Brings More Than 25 Years of Leadership and Business Development Experience ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.205531, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IGMS", "relevance_score": "0.256989", "ticker_sentiment_score": "0.017429", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCEL", "relevance_score": "0.130217", "ticker_sentiment_score": "0.013095", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.810303", "ticker_sentiment_score": "0.444142", "ticker_sentiment_label": "Bullish"}, {"ticker": "NKTR", "relevance_score": "0.130217", "ticker_sentiment_score": "0.013095", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer", "url": "https://www.globenewswire.com/news-release/2023/12/04/2789873/25619/en/Chimerix-Promotes-Michelle-LaSpaluto-to-Chief-Financial-Officer.html", "time_published": "20231204T120000", "authors": ["Chimerix", "Inc."], "summary": "Proven Leader Brings More Than 25 Years of Financial Experience Proven Leader Brings More Than 25 Years of Financial Experience ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.235446, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.642977", "ticker_sentiment_score": "0.353423", "ticker_sentiment_label": "Bullish"}]}, {"title": "Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2023/11/24/2785549/25619/en/Chimerix-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20231124T120000", "authors": ["Inc.", "Chimerix"], "summary": "DURHAM, N.C., Nov. 24, 2023 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , today announced that on November 20, 2023, the Compensation Committee of Chimerix's Board of Directors granted an inducement award to a new employee of non-qualified stock options to purchase 150,000 shares of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.355291, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.374312", "ticker_sentiment_score": "0.390153", "ticker_sentiment_label": "Bullish"}]}, {"title": "The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight", "url": "https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html", "time_published": "20231122T220100", "authors": ["DelveInsight Business Research", "LLP"], "summary": "The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.129719, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IPHA", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.013173", "ticker_sentiment_score": "0.026023", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSSS", "relevance_score": "0.013173", "ticker_sentiment_score": "0.120239", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKXJF", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAWN", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSKYF", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.013173", "ticker_sentiment_score": "0.026023", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWTX", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTHF", "relevance_score": "0.013173", "ticker_sentiment_score": "0.026023", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNSP", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.013173", "ticker_sentiment_score": "0.026023", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.026343", "ticker_sentiment_score": "0.037824", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZIA", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.039505", "ticker_sentiment_score": "0.102193", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.052656", "ticker_sentiment_score": "0.017928", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.013173", "ticker_sentiment_score": "0.026023", "ticker_sentiment_label": "Neutral"}, {"ticker": "VBIV", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOVA", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.039505", "ticker_sentiment_score": "0.022299", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNAC", "relevance_score": "0.013173", "ticker_sentiment_score": "0.026023", "ticker_sentiment_label": "Neutral"}, {"ticker": "INCY", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "KPTI", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.039505", "ticker_sentiment_score": "-0.000967", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVMD", "relevance_score": "0.013173", "ticker_sentiment_score": "-0.019011", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.013173", "ticker_sentiment_score": "0.040164", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Downgrades Chimerix  ( NASDAQ:CMRX )  to Sell", "url": "https://www.defenseworld.net/2023/11/05/stocknews-com-downgrades-chimerix-nasdaqcmrx-to-sell.html", "time_published": "20231105T065243", "authors": ["Defense World Staff"], "summary": "Chimerix ( NASDAQ:CMRX - Get Free Report ) was downgraded by stock analysts at StockNews.com from a \"hold\" rating to a \"sell\" rating in a research report issued on Friday. A number of other analysts have also recently weighed in on the company.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo.png?v=20221220142845", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.202805, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PFG", "relevance_score": "0.148731", "ticker_sentiment_score": "0.215569", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.866386", "ticker_sentiment_score": "0.343236", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023", "url": "https://www.globenewswire.com/news-release/2023/10/26/2767333/25619/en/Chimerix-to-Report-Third-Quarter-2023-Financial-Results-and-Provide-an-Operational-Update-on-November-2-2023.html", "time_published": "20231026T110000", "authors": ["Inc.", "Chimerix"], "summary": "DURHAM, N.C., Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.122692, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.613172", "ticker_sentiment_score": "0.183377", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying - Alzamend Neuro  ( NASDAQ:ALZN ) , Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/09/34948440/netsol-technologies-and-2-other-stocks-under-2-insiders-are-buying", "time_published": "20230927T131446", "authors": ["Lisa Levin"], "summary": "The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.194386, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALZN", "relevance_score": "0.558244", "ticker_sentiment_score": "0.24806", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NTWK", "relevance_score": "0.558244", "ticker_sentiment_score": "0.236377", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.558244", "ticker_sentiment_score": "0.357102", "ticker_sentiment_label": "Bullish"}]}, {"title": "Overview Of Value Stocks In The Healthcare Sector - Cross Country Healthcare  ( NASDAQ:CCRN ) , Voyager Therapeutics  ( NASDAQ:VYGR ) , Acorda Therapeutics  ( NASDAQ:ACOR ) , Spero Therapeutics  ( NASDAQ:SPRO ) ", "url": "https://www.benzinga.com/news/23/09/34693704/overview-of-value-stocks-in-the-healthcare-sector", "time_published": "20230918T144344", "authors": ["Benzinga Insights"], "summary": "A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.990678"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}], "overall_sentiment_score": 0.387064, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "SPRO", "relevance_score": "0.224903", "ticker_sentiment_score": "0.285552", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VYGR", "relevance_score": "0.224903", "ticker_sentiment_score": "0.285552", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.224903", "ticker_sentiment_score": "0.285552", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix to Participate in Upcoming Investor Conferences - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/23/09/g34228811/chimerix-to-participate-in-upcoming-investor-conferences", "time_published": "20230905T110000", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., Sept. 05, 2023 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that management will participate in two upcoming investor ... H.C.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.0449, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.586747", "ticker_sentiment_score": "0.130387", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in \"Cancer Discovery\" - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/23/08/g33876386/chimerix-announces-data-highlighting-clinical-efficacy-and-molecular-mechanisms-of-response-to-onc", "time_published": "20230816T140500", "authors": ["Globe Newswire"], "summary": "Patients Treated with ONC201 Demonstrated Median Overall Survival ( mOS ) of 21.7 Months in the Front-Line Setting, Post Radiation, Versus 12 Months mOS Historical Control ONC201 Treatment Disrupts Key Metabolic and Epigenetic Pathways", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.076421, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.266828", "ticker_sentiment_score": "0.072334", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.054359", "ticker_sentiment_score": "0.047886", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in \"Cancer Discovery\"", "url": "https://www.globenewswire.com/news-release/2023/08/16/2726539/25619/en/Chimerix-Announces-Data-Highlighting-Clinical-Efficacy-and-Molecular-Mechanisms-of-Response-to-ONC201-Treatment-of-H3-K27M-Mutant-Diffuse-Midline-Gliomas-Published-in-Cancer-Discov.html", "time_published": "20230816T140500", "authors": ["Chimerix", "Inc."], "summary": "Patients Treated with ONC201 Demonstrated Median Overall Survival ( mOS ) of 21.7 Months in the Front-Line Setting, Post Radiation, Versus 12 Months mOS Historical Control ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.067198, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.139534", "ticker_sentiment_score": "0.046448", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.046724", "ticker_sentiment_score": "0.050305", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( CMRX )  Reports Q2 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2131768/chimerix-cmrx-reports-q2-loss-misses-revenue-estimates", "time_published": "20230803T122517", "authors": ["Zacks Equity Research"], "summary": "Chimerix (CMRX) delivered earnings and revenue surprises of 8.70% and 95.91%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default311.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999892"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.105486, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EYE", "relevance_score": "0.138066", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.398148", "ticker_sentiment_score": "0.043705", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cerus  ( CERS )  Reports Q2 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2131337/cerus-cers-reports-q2-loss-lags-revenue-estimates", "time_published": "20230802T211508", "authors": ["Zacks Equity Research"], "summary": "Cerus (CERS) delivered earnings and revenue surprises of -40% and 4.77%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default305.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.107893, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CERS", "relevance_score": "0.406745", "ticker_sentiment_score": "0.04715", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.14131", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023 - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/23/07/g33414855/chimerix-to-report-second-quarter-2023-financial-results-and-provide-an-operational-update-on-augu", "time_published": "20230727T110000", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., July 27, 2023 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.108299, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.71174", "ticker_sentiment_score": "0.185351", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/23/06/g33033242/chimerix-announces-promotion-of-michael-t-andriole-to-president-and-chief-executive-officer", "time_published": "20230627T200500", "authors": ["Globe Newswire"], "summary": "Mike Sherman to Transition to Chair of the Board of Directors Martha Demski to Assume Role of Lead Independent Director DURHAM, N.C., June 27, 2023 ( GLOBE NEWSWIRE ) -- Chimerix, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}], "overall_sentiment_score": 0.211683, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.420316", "ticker_sentiment_score": "0.374237", "ticker_sentiment_label": "Bullish"}]}, {"title": "Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer", "url": "https://www.globenewswire.com/news-release/2023/06/27/2695772/25619/en/Chimerix-Announces-Promotion-of-Michael-T-Andriole-to-President-and-Chief-Executive-Officer.html", "time_published": "20230627T200500", "authors": ["Inc.", "Chimerix"], "summary": "Mike Sherman to Transition to Chair of the Board of Directors ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.21412, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.397288", "ticker_sentiment_score": "0.365984", "ticker_sentiment_label": "Bullish"}]}, {"title": "Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma  ( GBM )  and Diffuse Intrinsic Pontine Glioma  ( DIPG )  at White House - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/23/05/g32569879/chimerix-to-participate-in-cancer-moonshot-brain-cancers-forum-on-glioblastoma-gbm-and-diffuse-int", "time_published": "20230525T110000", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., May 25, 2023 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, announced that Joshua Allen, Ph.D., Chief Technology Officer of Chimerix, will ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.092325, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NHPEF", "relevance_score": "0.092213", "ticker_sentiment_score": "0.162349", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.512933", "ticker_sentiment_score": "0.157478", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma  ( GBM )  and Diffuse Intrinsic Pontine Glioma  ( DIPG )  at White House", "url": "https://www.globenewswire.com/news-release/2023/05/25/2675974/25619/en/Chimerix-to-Participate-in-Cancer-Moonshot-Brain-Cancers-Forum-on-Glioblastoma-GBM-and-Diffuse-Intrinsic-Pontine-Glioma-DIPG-at-White-House.html", "time_published": "20230525T110000", "authors": ["Chimerix", "Inc."], "summary": "Forum Aim is to Share Progress and Spur Actions to Advance the Field Forum Aim is to Share Progress and Spur Actions to Advance the Field ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.094986, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NHPEF", "relevance_score": "0.097062", "ticker_sentiment_score": "0.164725", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.457977", "ticker_sentiment_score": "0.15015", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks making the biggest moves midday: Yelp, AutoZone, Lowe's, Apple and more", "url": "https://www.cnbc.com/2023/05/23/stocks-making-biggest-midday-moves-yelp-autozone-lowes-and-more.html", "time_published": "20230523T162939", "authors": ["Alex Harring"], "summary": "These are some of the stocks posting the largest moves in midday trading Tuesday.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107071090-16542876452022-05-23t183555z_2079560731_rc25du92nc7c_rtrmadp_0_tesla-investor-calvert.jpeg?v=1684845028", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.998311"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.241004, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVR", "relevance_score": "0.04872", "ticker_sentiment_score": "0.083942", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.145437", "ticker_sentiment_score": "0.211122", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BAC", "relevance_score": "0.04872", "ticker_sentiment_score": "0.151676", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LFCR", "relevance_score": "0.04872", "ticker_sentiment_score": "0.24609", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GS", "relevance_score": "0.04872", "ticker_sentiment_score": "0.177952", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CCCS", "relevance_score": "0.097259", "ticker_sentiment_score": "0.090959", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.04872", "ticker_sentiment_score": "0.313322", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QTRX", "relevance_score": "0.097259", "ticker_sentiment_score": "0.189552", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZM", "relevance_score": "0.04872", "ticker_sentiment_score": "0.029954", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.04872", "ticker_sentiment_score": "0.046027", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMA", "relevance_score": "0.04872", "ticker_sentiment_score": "0.102054", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.04872", "ticker_sentiment_score": "0.177952", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMD", "relevance_score": "0.097259", "ticker_sentiment_score": "0.16299", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IART", "relevance_score": "0.04872", "ticker_sentiment_score": "0.015998", "ticker_sentiment_label": "Neutral"}]}, {"title": "7 Top Penny Stocks To Buy According To Insiders In May 2023", "url": "https://pennystocks.com/featured/2023/05/23/7-top-penny-stocks-to-buy-according-to-insiders-in-may-2023/", "time_published": "20230523T141344", "authors": ["J. Samuel"], "summary": "If you're curious about penny stocks, they offer an interesting niche. Whether you're new to trading these stocks or expanding your investment style, understanding what to look for and how to build a strong watch list is obviously important.", "banner_image": "https://pennystocks.com/wp-content/uploads/2021/08/best-penny-stocks-to-buy-insider-trading.jpg", "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999897"}], "overall_sentiment_score": 0.25498, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LAB", "relevance_score": "0.078482", "ticker_sentiment_score": "0.135658", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.117486", "ticker_sentiment_score": "0.005873", "ticker_sentiment_label": "Neutral"}]}, {"title": "A Look Into Healthcare Sector Value Stocks - Agile Therapeutics  ( NASDAQ:AGRX ) , Kiniksa Pharmaceuticals  ( NASDAQ:KNSA ) , Cullinan Oncology  ( NASDAQ:CGEM ) , Ocuphire Pharma  ( NASDAQ:OCUP ) ", "url": "https://www.benzinga.com/news/23/05/32509868/a-look-into-healthcare-sector-value-stocks", "time_published": "20230522T144335", "authors": ["Benzinga Insights"], "summary": "A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.336591, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AGRX", "relevance_score": "0.220809", "ticker_sentiment_score": "0.204891", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KNSA", "relevance_score": "0.220809", "ticker_sentiment_score": "0.204891", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CGEM", "relevance_score": "0.220809", "ticker_sentiment_score": "0.204891", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OCUP", "relevance_score": "0.220809", "ticker_sentiment_score": "0.204891", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.220809", "ticker_sentiment_score": "0.204891", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix  ( CMRX )  Reports Q1 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2089817/chimerix-cmrx-reports-q1-loss-misses-revenue-estimates", "time_published": "20230504T122520", "authors": ["Zacks Investment Research"], "summary": "Chimerix (CMRX) delivered earnings and revenue surprises of 0% and 19.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default104.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.09834, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EGRX", "relevance_score": "0.213048", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.411176", "ticker_sentiment_score": "0.07506", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( CMRX )  Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner", "url": "https://www.zacks.com/stock/news/2071857/chimerix-cmrx-loses--2468-in-4-weeks-heres-why-a-trend-reversal-may-be-around-the-corner", "time_published": "20230329T133507", "authors": ["Zacks Investment Research"], "summary": "Chimerix (CMRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default305.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.206276, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.485711", "ticker_sentiment_score": "0.284803", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Overview Of Value Stocks In The Healthcare Sector - Humacyte  ( NASDAQ:HUMA ) , Valneva  ( NASDAQ:VALN ) , Maravai LifeSciences  ( NASDAQ:MRVI ) , Retractable Technologies  ( AMEX:RVP ) ", "url": "https://www.benzinga.com/news/23/03/31322358/overview-of-value-stocks-in-the-healthcare-sector", "time_published": "20230313T144346", "authors": ["Benzinga Insights"], "summary": "A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Earnings", "relevance_score": "0.999326"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.388672, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "HUMA", "relevance_score": "0.200688", "ticker_sentiment_score": "0.250257", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRVI", "relevance_score": "0.200688", "ticker_sentiment_score": "0.331394", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VALN", "relevance_score": "0.200688", "ticker_sentiment_score": "0.250257", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.200688", "ticker_sentiment_score": "0.250257", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain - 27 Other Companies With Ties To Collapsed Bank - SVB Finl Gr  ( NASDAQ:SIVB ) ", "url": "https://www.benzinga.com/news/23/03/31309113/roku-has-26-of-cash-with-svb-financial-deposit-recovery-uncertain-27-other-companies-with-ties-to-co", "time_published": "20230311T192734", "authors": ["Chris Katje"], "summary": "The collapse of SVB Financial Group SIVB could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the company's Silicon Valley Bank.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/11/silicon_valley_bank_shutter5.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": -0.014211, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ROKU", "relevance_score": "0.309725", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVT", "relevance_score": "0.090645", "ticker_sentiment_score": "0.410545", "ticker_sentiment_label": "Bullish"}, {"ticker": "PRAX", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIFE", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBIO", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYO", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QS", "relevance_score": "0.090645", "ticker_sentiment_score": "-0.166522", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "STIM", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNPR", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIVB", "relevance_score": "0.090645", "ticker_sentiment_score": "-0.097551", "ticker_sentiment_label": "Neutral"}, {"ticker": "COHU", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IGMS", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RUN", "relevance_score": "0.090645", "ticker_sentiment_score": "-0.036432", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.090645", "ticker_sentiment_score": "-0.109021", "ticker_sentiment_label": "Neutral"}, {"ticker": "EIGR", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIRM", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBA", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNA", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "XFOR", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.090645", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Sunrun Down Over 10% On Silicon Valley Bank Exposure: What Other Companies Are Exposed? - Sunrun  ( NASDAQ:RUN ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/03/31301114/sunrun-down-over-10-on-silicon-valley-bank-exposure-what-other-companies-are-expose", "time_published": "20230310T185338", "authors": ["AJ Fabino"], "summary": "Shares of Sunrun Inc RUN, the largest residential solar developer in the U.S, fell by as much as 15% on Friday as a result of the news that Silicon Valley Bank has been closed by the California Department of Financial Protection and Innovation.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/10/solar_panels.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.081322, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RUN", "relevance_score": "0.602879", "ticker_sentiment_score": "0.327104", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SIVB", "relevance_score": "0.19117", "ticker_sentiment_score": "0.119327", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.19117", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.283323", "ticker_sentiment_score": "0.09634", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Lowers Chimerix  ( NASDAQ:CMRX )  to Hold", "url": "https://www.etfdailynews.com/2023/03/05/stocknews-com-lowers-chimerix-nasdaqcmrx-to-hold/", "time_published": "20230305T063448", "authors": ["MarketBeat News"], "summary": "Chimerix ( NASDAQ:CMRX - Get Rating ) was downgraded by StockNews.com from a \"buy\" rating to a \"hold\" rating in a research note issued on Friday. Separately, HC Wainwright reiterated a \"buy\" rating and issued a $11.00 price objective on shares of Chimerix in a research note on Friday.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo.png?v=20221220142845", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.185067, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ZS", "relevance_score": "0.105604", "ticker_sentiment_score": "0.131948", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.936889", "ticker_sentiment_score": "0.324769", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Green Thumb Industries Inc.  ( GTBIF )  Q4 Earnings Lag Estimates", "url": "https://www.zacks.com/stock/news/2060082/green-thumb-industries-inc-gtbif-q4-earnings-lag-estimates", "time_published": "20230301T002512", "authors": ["Zacks Investment Research"], "summary": "Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of -28.57% and 1.78%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default204.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.132544, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.136113", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/01/05/2583510/25619/en/Chimerix-to-Present-at-41st-Annual-J-P-Morgan-Healthcare-Conference.html", "time_published": "20230105T120000", "authors": ["Chimerix", "Inc."], "summary": "DURHAM, N.C., Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, Chief Executive Officer, will ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.090462, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.541149", "ticker_sentiment_score": "0.100657", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update", "url": "https://www.globenewswire.com/news-release/2022/12/08/2570699/25619/en/Chimerix-Announces-Successful-Launch-of-ONC201-Phase-3-ACTION-Study-at-Society-for-Neuro-Oncology-Conference-and-Provides-Operational-Update.html", "time_published": "20221208T220000", "authors": ["Chimerix", "Inc."], "summary": "- Natural Disease History study indicates median overall survival in recurrent H3 K27M-mutant diffuse glioma of 5.1 months compared to 13.7 months in the prior ONC201 Phase 2 efficacy analysis ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/0b47b8b6-922b-4b6b-8fc0-7cfe9cba4c90?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.202886, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.141559", "ticker_sentiment_score": "0.198241", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBS", "relevance_score": "0.028456", "ticker_sentiment_score": "0.236162", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.028456", "ticker_sentiment_score": "0.029338", "ticker_sentiment_label": "Neutral"}]}, {"title": "Speedier drug approvals hit slowdown as FDA faces scrutiny", "url": "https://apnews.com/article/health-cancer-business-congress-drug-approvals-e029b9f3f72b4282ad39d2d00902edfe", "time_published": "20221207T050130", "authors": [], "summary": "WASHINGTON ( AP ) - Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency's own leaders.", "banner_image": "https://storage.googleapis.com/afs-prod/media/a3eed2c3994d44339a178e2d9d0bb6ae/3000.webp", "source": "Associated Press", "category_within_source": "Markets", "source_domain": "apnews.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.073413, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CLVT", "relevance_score": "0.041538", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HHC", "relevance_score": "0.041538", "ticker_sentiment_score": "0.163749", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.041538", "ticker_sentiment_score": "0.027821", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( CMRX )  Upgraded to Buy: What Does It Mean for the Stock?", "url": "https://www.zacks.com/stock/news/2023355/chimerix-cmrx-upgraded-to-buy-what-does-it-mean-for-the-stock", "time_published": "20221129T170006", "authors": ["Zacks Investment Research"], "summary": "Chimerix (CMRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default21.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}], "overall_sentiment_score": 0.301452, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.366961", "ticker_sentiment_score": "0.306038", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Emergent BioSolutions  ( EBS )  Q3 2022 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2022/11/08/emergent-biosolutions-ebs-q3-2022-earnings-call-tr/", "time_published": "20221109T040034", "authors": ["Motley Fool Transcribing"], "summary": "EBS earnings call for the period ending September 30, 2022.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.98396"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.211037, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JPM", "relevance_score": "0.013997", "ticker_sentiment_score": "0.034557", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.02799", "ticker_sentiment_score": "0.118497", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.013997", "ticker_sentiment_score": "0.139159", "ticker_sentiment_label": "Neutral"}]}, {"title": "Emergent BioSolutions Reports Financial Results For Third Quarter 2022", "url": "https://www.globenewswire.com/news-release/2022/11/08/2551487/33240/en/Emergent-BioSolutions-Reports-Financial-Results-For-Third-Quarter-2022.html", "time_published": "20221108T211600", "authors": ["Inc.", "Emergent Biosolutions"], "summary": "GAITHERSBURG, Md., Nov. 08, 2022 ( GLOBE NEWSWIRE ) -- Emergent BioSolutions Inc. ( NYSE: EBS ) today reported financial results for the third quarter ended September 30, 2022.", "banner_image": "https://ml.globenewswire.com/Resource/Download/56a9097d-af91-4bcf-8c42-5905e1614ef1?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}], "overall_sentiment_score": 0.104331, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.049861", "ticker_sentiment_score": "-0.007995", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.024943", "ticker_sentiment_score": "0.066435", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.037407", "ticker_sentiment_score": "0.094294", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( NASDAQ:CMRX )  Stock Rating Upgraded by StockNews.com", "url": "https://www.etfdailynews.com/2022/11/06/chimerix-nasdaqcmrx-stock-rating-upgraded-by-stocknews-com/", "time_published": "20221106T060646", "authors": ["MarketBeat News"], "summary": "Chimerix ( NASDAQ:CMRX - Get Rating ) was upgraded by analysts at StockNews.com from a \"hold\" rating to a \"buy\" rating in a research note issued to investors on Friday. Separately, Capital One Financial initiated coverage on shares of Chimerix in a research report on Wednesday, September 7th.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo.JPG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.249155, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PRU", "relevance_score": "0.079656", "ticker_sentiment_score": "0.168468", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.866386", "ticker_sentiment_score": "0.387151", "ticker_sentiment_label": "Bullish"}, {"ticker": "COF", "relevance_score": "0.079656", "ticker_sentiment_score": "0.007138", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Etsy Shares Are Trading Sharply Higher; Here Are 31 Stocks Moving Premarket - Akso Health Group  ( NASDAQ:AHG ) , AnPac Bio-Medical Science  ( NASDAQ:ANPC ) ", "url": "https://www.benzinga.com/news/22/11/29542636/why-etsy-shares-are-trading-sharply-higher-here-are-31-stocks-moving-premarket", "time_published": "20221103T115017", "authors": ["Lisa Levin"], "summary": "COMSovereign Holding Corp. COMS shares rose 34.7% to $0.0858 in pre-market trading after gaining over 12% on Wednesday. Biophytis S.A. BPTS rose 31.4% to $0.7751 in pre-market trading after the company disclosed positive post-hoc analysis of the Phase 2-3 COVA clinical study strongly supporting ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/11/03/image-etsy.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.975168"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.997874"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.002431, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AHG", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.343916", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LNC", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.043003", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.157827", "ticker_sentiment_score": "-0.214839", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TRVG", "relevance_score": "0.157827", "ticker_sentiment_score": "0.240106", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LUMN", "relevance_score": "0.105604", "ticker_sentiment_score": "0.066972", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMS", "relevance_score": "0.105604", "ticker_sentiment_score": "0.286", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IRNT", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATUS", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.181015", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "QTNT", "relevance_score": "0.157827", "ticker_sentiment_score": "-0.427712", "ticker_sentiment_label": "Bearish"}, {"ticker": "STRY", "relevance_score": "0.157827", "ticker_sentiment_score": "0.112531", "ticker_sentiment_label": "Neutral"}, {"ticker": "AREB", "relevance_score": "0.157827", "ticker_sentiment_score": "-0.060601", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTS", "relevance_score": "0.105604", "ticker_sentiment_score": "0.230203", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JWEL", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.070458", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSH", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.326449", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SIEN", "relevance_score": "0.157827", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTIC", "relevance_score": "0.157827", "ticker_sentiment_score": "-0.044131", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.105604", "ticker_sentiment_score": "0.138481", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINO", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.046686", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSR", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.182168", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EGIO", "relevance_score": "0.157827", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROM", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.296938", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RUN", "relevance_score": "0.105604", "ticker_sentiment_score": "0.229109", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OIG", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.290376", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CMRX", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.105604", "ticker_sentiment_score": "0.217078", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FTNT", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.23239", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HOOD", "relevance_score": "0.105604", "ticker_sentiment_score": "0.203959", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANPC", "relevance_score": "0.105604", "ticker_sentiment_score": "0.212704", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DBGI", "relevance_score": "0.157827", "ticker_sentiment_score": "0.081006", "ticker_sentiment_label": "Neutral"}]}, {"title": "Perrigo  ( PRGO )  Earnings Expected to Grow: Should You Buy?", "url": "https://www.zacks.com/stock/news/2011831/perrigo-prgo-earnings-expected-to-grow-should-you-buy", "time_published": "20221101T140122", "authors": ["Zacks Investment Research"], "summary": "Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default201.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.135461, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.177802", "ticker_sentiment_score": "0.050878", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRGO", "relevance_score": "0.263942", "ticker_sentiment_score": "0.058023", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022 - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/22/10/g29448705/chimerix-to-report-third-quarter-2022-financial-results-and-provide-an-operational-update-on-novem", "time_published": "20221027T203000", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., Oct. 27, 2022 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.103552, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.690822", "ticker_sentiment_score": "0.182955", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022", "url": "https://www.globenewswire.com/news-release/2022/10/27/2543431/25619/en/Chimerix-to-Report-Third-Quarter-2022-Financial-Results-and-Provide-an-Operational-Update-on-November-3-2022.html", "time_published": "20221027T203000", "authors": ["Inc.", "Chimerix"], "summary": "DURHAM, N.C., Oct. 27, 2022 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/9b5bc625-104d-4a8b-9efc-877699d633d4?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.122715, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.613172", "ticker_sentiment_score": "0.183401", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Chimerix  ( CMRX )  Earnings Expected to Grow: What to Know Ahead of Q3 Release", "url": "https://www.zacks.com/stock/news/1998663/chimerix-cmrx-earnings-expected-to-grow-what-to-know-ahead-of-q3-release", "time_published": "20221027T140217", "authors": ["Zacks Investment Research"], "summary": "Chimerix (CMRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default131.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.152011, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "OMI", "relevance_score": "0.176502", "ticker_sentiment_score": "-0.033047", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.262052", "ticker_sentiment_score": "0.173815", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Boston Scientific  ( BSX )  Q3 Earnings Miss, Operating Margin Up", "url": "https://www.zacks.com/stock/news/1997822/boston-scientific-bsx-q3-earnings-miss-operating-margin-up", "time_published": "20221026T155200", "authors": ["Zacks Investment Research"], "summary": "Boston Scientific's (BSX) Q3 revenues reflect double-digit organic revenue growth across the majority of its businesses.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a0/644.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.117895, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HUM", "relevance_score": "0.191549", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.144275", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.372216", "ticker_sentiment_score": "0.121206", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.144275", "ticker_sentiment_score": "0.066792", "ticker_sentiment_label": "Neutral"}]}, {"title": "CVS Health  ( CVS )  to Report Q3 Earnings: What's in the Cards?", "url": "https://www.zacks.com/stock/news/1997032/cvs-health-cvs-to-report-q3-earnings-whats-in-the-cards", "time_published": "20221025T163300", "authors": ["Zacks Investment Research"], "summary": "CVS Health's (CVS) digital capabilities are anticipated to have enhanced consumer engagement across all CVS Health businesses in Q3.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5a/926.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.34639, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.490323", "ticker_sentiment_score": "0.600119", "ticker_sentiment_label": "Bullish"}, {"ticker": "HUM", "relevance_score": "0.130926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.043818", "ticker_sentiment_score": "0.079285", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.130926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.087503", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "CVS Health  ( CVS )  to Report Q3 Earnings: What's in the Cards?", "url": "https://www.zacks.com/stock/news/1997032/cvs-health-cvs-to-report-q3-earnings-whats-in-the-cards", "time_published": "20221025T163300", "authors": ["Zacks Investment Research"], "summary": "CVS Health's (CVS) digital capabilities are anticipated to have enhanced consumer engagement across all CVS Health businesses in Q3.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5a/926.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.367371, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.484191", "ticker_sentiment_score": "0.606725", "ticker_sentiment_label": "Bullish"}, {"ticker": "HUM", "relevance_score": "0.129052", "ticker_sentiment_score": "0.112311", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.043186", "ticker_sentiment_score": "0.07915", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.129052", "ticker_sentiment_score": "0.115842", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.086245", "ticker_sentiment_score": "0.074985", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's in the Cards for Illumina  ( ILMN )  in Q3 Earnings?", "url": "https://www.zacks.com/stock/news/1996715/whats-in-the-cards-for-illumina-ilmn-in-q3-earnings", "time_published": "20221025T133900", "authors": ["Zacks Investment Research"], "summary": "The extended lockdown issues in limited geographies, including Greater China, where Illumina (ILMN) has extensive business, are expected to have adversely impacted its top line during the third quarter.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/79/359.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.156738, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HUM", "relevance_score": "0.163909", "ticker_sentiment_score": "0.128783", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.163909", "ticker_sentiment_score": "0.132823", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.320974", "ticker_sentiment_score": "0.283726", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.109705", "ticker_sentiment_score": "0.079733", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.054983", "ticker_sentiment_score": "-0.033102", "ticker_sentiment_label": "Neutral"}]}, {"title": "Charles River  ( CRL )  to Report Q3 Earnings: What's in Store?", "url": "https://www.zacks.com/stock/news/1996137/charles-river-crl-to-report-q3-earnings-whats-in-store", "time_published": "20221024T132700", "authors": ["Zacks Investment Research"], "summary": "Charles River's (CRL) CRADLE initiative for small and large biopharmaceutical clients is anticipated to have maintained its growth momentum.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/0c/2749.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.294226, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HEMA", "relevance_score": "0.048327", "ticker_sentiment_score": "0.122498", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUM", "relevance_score": "0.144275", "ticker_sentiment_score": "0.119079", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRL", "relevance_score": "0.191549", "ticker_sentiment_score": "0.181041", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MCK", "relevance_score": "0.144275", "ticker_sentiment_score": "0.122821", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.096477", "ticker_sentiment_score": "0.076753", "ticker_sentiment_label": "Neutral"}]}, {"title": "Zimmer Biomet  ( ZBH )  to Report Q3 Earnings: What's in Store?", "url": "https://www.zacks.com/stock/news/1996091/zimmer-biomet-zbh-to-report-q3-earnings-whats-in-store", "time_published": "20221024T130200", "authors": ["Zacks Investment Research"], "summary": "Zimmer Biomet (ZBH) might have faced an upheaval in business, thanks to the global inflationary situation in terms of mounting labor and raw material costs.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/27/21481.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.999997"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.195065, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HUM", "relevance_score": "0.150592", "ticker_sentiment_score": "0.122097", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBH", "relevance_score": "0.387374", "ticker_sentiment_score": "0.132419", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.150592", "ticker_sentiment_score": "0.125932", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.100729", "ticker_sentiment_score": "0.07763", "ticker_sentiment_label": "Neutral"}]}, {"title": "Non-COVID Diagnostics Sales to Aid Hologic  ( HOLX )  Q4 Earnings", "url": "https://www.zacks.com/stock/news/1995468/non-covid-diagnostics-sales-to-aid-hologic-holx-q4-earnings", "time_published": "20221021T120100", "authors": ["Zacks Investment Research"], "summary": "Hologic's (HOLX) Molecular Diagnostics sales are likely to have been affected by the significant drop in demand for COVID-19 testing.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/94/1507.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.999953"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.21152, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HUM", "relevance_score": "0.165409", "ticker_sentiment_score": "0.129559", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.422366", "ticker_sentiment_score": "0.231329", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MCK", "relevance_score": "0.165409", "ticker_sentiment_score": "0.133623", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.110717", "ticker_sentiment_score": "0.07999", "ticker_sentiment_label": "Neutral"}]}, {"title": "Quest Diagnostics  ( DGX )  Beats on Q3 Earnings, Ups Revenue View", "url": "https://www.zacks.com/stock/news/1995233/quest-diagnostics-dgx-beats-on-q3-earnings-ups-revenue-view", "time_published": "20221020T170300", "authors": ["Zacks Investment Research"], "summary": "Banking on consistent improvement in the company's Base business, Quest Diagnostics (DGX) raised its full-year 2022 revenue guidance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/1450.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.176716, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "III", "relevance_score": "0.055236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUM", "relevance_score": "0.164656", "ticker_sentiment_score": "0.162931", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DGX", "relevance_score": "0.467081", "ticker_sentiment_score": "0.21495", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MCK", "relevance_score": "0.110209", "ticker_sentiment_score": "0.137168", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.110209", "ticker_sentiment_score": "0.185848", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Factors Setting the Tone for HCA Healthcare  ( HCA )  Q3 Earnings", "url": "https://www.zacks.com/stock/news/1993737/factors-setting-the-tone-for-hca-healthcare-hca-q3-earnings", "time_published": "20221018T174000", "authors": ["Zacks Investment Research"], "summary": "HCA Healthcare's (HCA) third-quarter results are expected to reflect better emergency room visits and outpatient surgeries, partly offset by the continued incidence of labor costs.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6c/383.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.162273, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BMRN", "relevance_score": "0.114682", "ticker_sentiment_score": "0.129108", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.05749", "ticker_sentiment_score": "0.055094", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.114682", "ticker_sentiment_score": "0.111351", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCA", "relevance_score": "0.651499", "ticker_sentiment_score": "0.231994", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Will UnitedHealth Group  ( UNH )  Beat Q3 Earnings Estimates?", "url": "https://www.zacks.com/stock/news/1990522/will-unitedhealth-group-unh-beat-q3-earnings-estimates", "time_published": "20221011T163100", "authors": ["Zacks Investment Research"], "summary": "UnitedHealth Group's (UNH) third-quarter results are likely to benefit from higher premiums and membership growth in its UnitedHealthcare unit, partly offset by elevated technology investment costs.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ef/386.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.286776, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HUM", "relevance_score": "0.155451", "ticker_sentiment_score": "0.202633", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UNH", "relevance_score": "0.567144", "ticker_sentiment_score": "0.416825", "ticker_sentiment_label": "Bullish"}, {"ticker": "CMRX", "relevance_score": "0.104002", "ticker_sentiment_score": "0.109592", "ticker_sentiment_label": "Neutral"}]}, {"title": "$1.2 Million Bet On ChromaDex? Check Out These 4 Penny Stocks Insiders Are Buying - ChromaDex  ( NASDAQ:CDXC ) , Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/22/10/29134803/1-2-million-bet-on-chromadex-check-out-these-4-penny-stocks-insiders-are-buying", "time_published": "20221004T124132", "authors": ["Lisa Levin"], "summary": "The Dow Jones jumped by more than 750 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/10/04/image31_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.253561, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TCON", "relevance_score": "0.388879", "ticker_sentiment_score": "0.323854", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RVPH", "relevance_score": "0.388879", "ticker_sentiment_score": "0.076786", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXC", "relevance_score": "0.45825", "ticker_sentiment_score": "0.393425", "ticker_sentiment_label": "Bullish"}, {"ticker": "CMRX", "relevance_score": "0.388879", "ticker_sentiment_score": "0.349943", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBS", "relevance_score": "0.081001", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Emergent  ( EBS )  Acquires Worldwide Rights to Smallpox Antiviral", "url": "https://www.zacks.com/stock/news/1985459/emergent-ebs-acquires-worldwide-rights-to-smallpox-antiviral", "time_published": "20220927T141300", "authors": ["Zacks Investment Research"], "summary": "Emergent (EBS) completes the acquisition of worldwide rights to Tembexa, an FDA-approved smallpox oral antiviral for all ages, from Chimerix.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.21484, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APTO", "relevance_score": "0.391311", "ticker_sentiment_score": "0.207377", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ATRA", "relevance_score": "0.391311", "ticker_sentiment_score": "0.21", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.526455", "ticker_sentiment_score": "0.367915", "ticker_sentiment_label": "Bullish"}, {"ticker": "EBS", "relevance_score": "0.241284", "ticker_sentiment_score": "0.256292", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA\u00ae  ( brincidofovir ) , the First FDA-Approved Smallpox Oral Antiviral for All Ages", "url": "https://www.globenewswire.com/news-release/2022/09/26/2522859/33240/en/Emergent-BioSolutions-Completes-Acquisition-of-Exclusive-Worldwide-Rights-to-TEMBEXA-brincidofovir-the-First-FDA-Approved-Smallpox-Oral-Antiviral-for-All-Ages.html", "time_published": "20220926T201200", "authors": ["Inc.", "Emergent Biosolutions"], "summary": "GAITHERSBURG, Md., Sept. 26, 2022 ( GLOBE NEWSWIRE ) -- Emergent BioSolutions Inc. ( NYSE: EBS ) announced today that it has completed its acquisition of exclusive worldwide rights to TEMBEXA\u00ae ( brincidofovir ) , the first oral antiviral approved by the U.S.", "banner_image": "https://ml.globenewswire.com/Resource/Download/56a9097d-af91-4bcf-8c42-5905e1614ef1?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.05297, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.172097", "ticker_sentiment_score": "0.114004", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.069294", "ticker_sentiment_score": "0.09234", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions - Chimerix  ( NASDAQ:CMRX ) ", "url": "https://www.benzinga.com/pressreleases/22/09/g29020007/chimerix-announces-closing-of-tembexa-sale-to-emergent-biosolutions", "time_published": "20220926T200500", "authors": ["Globe Newswire"], "summary": "- $238 Million in Upfront Payment Received at Closing with Additional $136.5 Million in Potential Milestone Payments Plus Royalties - DURHAM, N.C., Sept. 26, 2022 ( GLOBE NEWSWIRE ) -- Chimerix, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.143866, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.458446", "ticker_sentiment_score": "0.285432", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBS", "relevance_score": "0.206392", "ticker_sentiment_score": "0.113893", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions", "url": "https://www.globenewswire.com/news-release/2022/09/26/2522851/25619/en/Chimerix-Announces-Closing-of-TEMBEXA-Sale-to-Emergent-BioSolutions.html", "time_published": "20220926T200500", "authors": ["Chimerix", "Inc."], "summary": "- $238 Million in Upfront Payment Received at Closing with Additional $136.5 Million in Potential Milestone Payments Plus Royalties ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/9b5bc625-104d-4a8b-9efc-877699d633d4?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.080956, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.323078", "ticker_sentiment_score": "0.205177", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBS", "relevance_score": "0.165031", "ticker_sentiment_score": "0.08887", "ticker_sentiment_label": "Neutral"}]}, {"title": "Implied Volatility Surging for Chimerix  ( CMRX )  Stock Options", "url": "https://www.zacks.com/stock/news/1975163/implied-volatility-surging-for-chimerix-cmrx-stock-options", "time_published": "20220901T124800", "authors": ["Zacks Investment Research"], "summary": "Investors need to pay close attention to Chimerix (CMRX) stock based on the movements in the options market lately.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.097422, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.565345", "ticker_sentiment_score": "0.162641", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Chimerix Stock Is Soaring Today", "url": "https://www.benzinga.com/news/22/08/28670221/why-chimerix-stock-is-soaring-today", "time_published": "20220829T152938", "authors": ["Adam Eckert"], "summary": "Chimerix Inc CMRX shares are trading higher Monday after the company won a multi-year contract with the Biomedical Advanced Research and Development Authority ( BARDA ) in the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/08/29/52097193159_6be76f8d61_k.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.203516, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.396261", "ticker_sentiment_score": "0.310115", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBS", "relevance_score": "0.082677", "ticker_sentiment_score": "0.124378", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox", "url": "https://www.globenewswire.com/news-release/2022/08/29/2506114/25619/en/Chimerix-Awarded-BARDA-Contract-for-TEMBEXA-as-Medical-Countermeasure-for-Smallpox.html", "time_published": "20220829T144500", "authors": ["Chimerix", "Inc."], "summary": "- Initial Procurement of 319,000 Treatment Courses for $115M with Additional Procurements at BARDA's Discretion Over 10 Years ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/9b5bc625-104d-4a8b-9efc-877699d633d4?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.097564, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.27535", "ticker_sentiment_score": "0.178956", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBS", "relevance_score": "0.230892", "ticker_sentiment_score": "0.195995", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Demand for Comprehensive Cleaning Services Grow Post-Pandemic", "url": "https://www.prnewswire.com/news-releases/demand-for-comprehensive-cleaning-services-grow-post-pandemic-301612967.html", "time_published": "20220826T130000", "authors": ["FinancialBuzz.com"], "summary": "NEW YORK, Aug. 26, 2022 /PRNewswire/ -- Due to the growing implementation of AI and automation in household equipment, the domestic robot market reached a high growth rate in recent years. For example, the development of machine vision cameras has rapidly expanded.", "banner_image": "", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.998356"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.22708, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.156843", "ticker_sentiment_score": "0.138364", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.019731", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EJH", "relevance_score": "0.117967", "ticker_sentiment_score": "0.079645", "ticker_sentiment_label": "Neutral"}, {"ticker": "WM", "relevance_score": "0.137446", "ticker_sentiment_score": "0.087725", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.019731", "ticker_sentiment_score": "0.110761", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.233369", "ticker_sentiment_score": "0.300764", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IT", "relevance_score": "0.019731", "ticker_sentiment_score": "0.11815", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.098416", "ticker_sentiment_score": "0.106494", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( CMRX )  Q2 2022 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2022/08/09/chimerix-cmrx-q2-2022-earnings-call-transcript/", "time_published": "20220809T080048", "authors": ["Motley Fool Transcribing"], "summary": "CMRX earnings call for the period ending June 30, 2022.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.219691, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.049036", "ticker_sentiment_score": "0.122645", "ticker_sentiment_label": "Neutral"}]}, {"title": "10 Top Monkeypox Stocks To Watch Right Now", "url": "https://pennystocks.com/featured/2022/08/04/10-top-monkeypox-stocks-to-watch-right-now/", "time_published": "20220804T182757", "authors": ["J. Samuel"], "summary": "Penny Stocks To Watch & More If You're Concerned About Monkeypox Are you concerned about monkeypox? Even if you're not, you might be interested in taking advantage of the speculative environment in the stock market today. If so, having a list of penny stocks and higher-priced stocks to watch ...", "banner_image": null, "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.107039, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.023673", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.023673", "ticker_sentiment_score": "0.397338", "ticker_sentiment_label": "Bullish"}, {"ticker": "TNXP", "relevance_score": "0.070935", "ticker_sentiment_score": "-0.022116", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.094482", "ticker_sentiment_score": "0.07651", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.117948", "ticker_sentiment_score": "0.02348", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.047324", "ticker_sentiment_score": "0.038379", "ticker_sentiment_label": "Neutral"}]}, {"title": "MonkeyPox Stocks To Buy Right Now? 3 To Know", "url": "https://stockmarket.com/featured/monkeypox-stocks-to-buy-right-now-3-to-know-2022-08-02", "time_published": "20220802T135040", "authors": ["Brandon Michael"], "summary": "Check Out These Three MonkeyPox Stocks Making Headlines In The Stock Market Today Unless you've been living under a rock, it's likely you've seen all the monkeypox headlines in the stock market today. Health authorities worldwide are actively looking for a way effective ways to stop the monkeypox ...", "banner_image": "https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2022/08/BVNRY-stock-.jpg", "source": "StockMarket.com", "category_within_source": "n/a", "source_domain": "stockmarket.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999822"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.228004, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SIGA", "relevance_score": "0.369076", "ticker_sentiment_score": "0.160912", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BVNKF", "relevance_score": "0.042571", "ticker_sentiment_score": "-0.081964", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.085022", "ticker_sentiment_score": "0.036836", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.251247", "ticker_sentiment_score": "0.169766", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Emergent BioSolutions  ( EBS )  Q2 2022 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2022/08/01/emergent-biosolutions-ebs-q2-2022-earnings-call-tr/", "time_published": "20220802T033035", "authors": ["Motley Fool Transcribing"], "summary": "EBS earnings call for the period ending June 30, 2022.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.998962"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.576289"}], "overall_sentiment_score": 0.241453, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.006948", "ticker_sentiment_score": "-0.072951", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHGUF", "relevance_score": "0.006948", "ticker_sentiment_score": "0.058351", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.03473", "ticker_sentiment_score": "0.068965", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.013896", "ticker_sentiment_score": "0.108258", "ticker_sentiment_label": "Neutral"}]}, {"title": "Emergent BioSolutions Reports Financial Results for Second Quarter 2022", "url": "https://www.globenewswire.com/news-release/2022/08/01/2489875/33240/en/Emergent-BioSolutions-Reports-Financial-Results-for-Second-Quarter-2022.html", "time_published": "20220801T200500", "authors": ["Emergent Biosolutions", "Inc."], "summary": "GAITHERSBURG, Md., Aug. 01, 2022 ( GLOBE NEWSWIRE ) -- Emergent BioSolutions Inc. ( NYSE: EBS ) today reported financial results for the second quarter ended June 30, 2022.", "banner_image": "https://ml.globenewswire.com/Resource/Download/56a9097d-af91-4bcf-8c42-5905e1614ef1?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.98396"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.159504, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.021728", "ticker_sentiment_score": "0.011678", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.021728", "ticker_sentiment_score": "0.085611", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.032587", "ticker_sentiment_score": "0.08844", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Emergent BioSolutions Stock Is Jumping This Week", "url": "https://www.fool.com/investing/2022/07/28/why-emergent-biosolutions-stock-is-jumping-this-we/", "time_published": "20220728T204600", "authors": ["Keith Speights"], "summary": "Worries about the monkeypox outbreak have driven Emergent's shares higher.", "banner_image": "https://g.foolcdn.com/editorial/images/681511/vaccine-being-given-to-teen-boy.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.023902, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SPGI", "relevance_score": "0.146916", "ticker_sentiment_score": "-0.029099", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.146916", "ticker_sentiment_score": "0.005107", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.288893", "ticker_sentiment_score": "-0.050197", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.733479", "ticker_sentiment_score": "-0.035116", "ticker_sentiment_label": "Neutral"}]}, {"title": "Crude Oil Drops 1%; General Motors Earnings Miss Views", "url": "https://www.benzinga.com/news/earnings/22/07/28212522/crude-oil-drops-1-general-motors-earnings-miss-views", "time_published": "20220726T183646", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Tuesday. The Dow traded down 0.46% to 31,842.46 while the NASDAQ fell 1.80% to 11,571.14. The S&P also fell, dropping, 1.06% to 3,924.7.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/26/image-general-motors.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.043211, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SSNLF", "relevance_score": "0.062597", "ticker_sentiment_score": "0.18517", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AYLA", "relevance_score": "0.124809", "ticker_sentiment_score": "0.243025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TALS", "relevance_score": "0.124809", "ticker_sentiment_score": "0.306806", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GM", "relevance_score": "0.246582", "ticker_sentiment_score": "-0.063404", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGT", "relevance_score": "0.124809", "ticker_sentiment_score": "0.213962", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LKCO", "relevance_score": "0.124809", "ticker_sentiment_score": "0.193029", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "REVB", "relevance_score": "0.186259", "ticker_sentiment_score": "0.124549", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.039329", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.124809", "ticker_sentiment_score": "0.306806", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.062597", "ticker_sentiment_score": "-0.130067", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq Tumbles 200 Points; McDonald's Posts Upbeat Q2 Earnings", "url": "https://www.benzinga.com/news/earnings/22/07/28210367/nasdaq-tumbles-200-points-mcdonalds-posts-upbeat-q2-earnings", "time_published": "20220726T163041", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 200 points on Tuesday. The Dow traded down 0.58% to 31,803.45 while the NASDAQ fell 1.71% to 11,581.11. The S&P also fell, dropping, 1.10% to 3,923.15.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/26/image-mcdonalds.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.064706, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SSNLF", "relevance_score": "0.064276", "ticker_sentiment_score": "0.185313", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AYLA", "relevance_score": "0.128135", "ticker_sentiment_score": "0.245945", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TALS", "relevance_score": "0.128135", "ticker_sentiment_score": "0.310403", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDNDF", "relevance_score": "0.128135", "ticker_sentiment_score": "-0.034289", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGT", "relevance_score": "0.128135", "ticker_sentiment_score": "0.216554", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LKCO", "relevance_score": "0.128135", "ticker_sentiment_score": "0.195378", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "REVB", "relevance_score": "0.19117", "ticker_sentiment_score": "0.126962", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.128135", "ticker_sentiment_score": "-0.039893", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.128135", "ticker_sentiment_score": "0.310403", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MCD", "relevance_score": "0.128135", "ticker_sentiment_score": "0.389333", "ticker_sentiment_label": "Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.064276", "ticker_sentiment_score": "-0.130147", "ticker_sentiment_label": "Neutral"}]}, {"title": "Hot Penny Stocks To Watch As Monkeypox Gets WHO GHE Designation", "url": "https://pennystocks.com/featured/2022/07/25/hot-penny-stocks-to-watch-as-monkeypox-gets-who-ghe-designation/", "time_published": "20220725T150844", "authors": ["J. Samuel"], "summary": "If you thought monkeypox was a fad, you might want to reconsider. While it isn't as significant ( so far ) as other viruses like coronavirus, it is spreading globally. Over the weekend, the World Health Organization inadvertently gave a boost to attention to certain penny stocks, mainly monkeypox ...", "banner_image": "https://pennystocks.com/wp-content/uploads/2022/06/penny-stocks-to-buy-Chimerix-CMRX-stock.jpg", "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.998962"}], "overall_sentiment_score": 0.172556, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOVX", "relevance_score": "0.107016", "ticker_sentiment_score": "0.08485", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.071463", "ticker_sentiment_score": "0.111351", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.142355", "ticker_sentiment_score": "0.050767", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.071463", "ticker_sentiment_score": "-0.028121", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.071463", "ticker_sentiment_score": "0.045209", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Is Chimerix Stock Trading Higher Today?", "url": "https://www.benzinga.com/markets/penny-stocks/22/07/28186336/chimerix-stock-is-surging-heres-why", "time_published": "20220725T130742", "authors": ["Adam Eckert"], "summary": "Chimerix Inc CMRX shares are trading higher Monday morning after the World Health Organization ( WHO ) declared monkeypox a public health emergency of global concern.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/25/lab-g3b7713184_1920.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": -0.067175, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.740604", "ticker_sentiment_score": "0.011893", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Revelation Biosciences is Trading Higher By 115%: Here's 22 Stocks Moving Premarket", "url": "https://www.benzinga.com/news/22/07/28184385/why-revelation-biosciences-is-trading-higher-by-115-heres-22-stocks-moving-premarket", "time_published": "20220725T112659", "authors": ["Lisa Levin"], "summary": "Revelation Biosciences, Inc. REVB rose 115.3% to $1.40 in pre-market trading after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis. GeoVax Labs, Inc. GOVX rose 41.8% to $0.9013 in pre-market trading after declining 8% on Friday. Chimerix, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/25/image13_0.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.897321"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.265703, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "CNEY", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.257965", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "STAF", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.257965", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FAZE", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.272901", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GFAI", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.188765", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ADXN", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.196452", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SDIG", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.371829", "ticker_sentiment_label": "Bearish"}, {"ticker": "CCNC", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.353359", "ticker_sentiment_label": "Bearish"}, {"ticker": "AERC", "relevance_score": "0.169676", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.257965", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CMRX", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.24162", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INPX", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.277181", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TBLT", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.24162", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "THMO", "relevance_score": "0.169676", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.169676", "ticker_sentiment_score": "0.14393", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.221124", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACRX", "relevance_score": "0.169676", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.085324", "ticker_sentiment_score": "-0.252801", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SIGA", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.221124", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "REVB", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.111129", "ticker_sentiment_label": "Neutral"}, {"ticker": "VS", "relevance_score": "0.252114", "ticker_sentiment_score": "0.077971", "ticker_sentiment_label": "Neutral"}]}, {"title": "This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday", "url": "https://www.benzinga.com/news/22/07/28182325/this-technology-stock-surged-235-here-are-77-biggest-movers-from-friday", "time_published": "20220725T083855", "authors": ["Lisa Levin"], "summary": "AMTD Digital Inc. HKD climbed 234.7% to settle at $68.00 on Friday amid continued post-IPO volatility. Pagaya Technologies Ltd. PGY shares jumped 118.9% to close at $11.71 on Friday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/25/image15.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.998932"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.06796, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AMTD", "relevance_score": "0.114819", "ticker_sentiment_score": "0.019359", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.057559", "ticker_sentiment_score": "0.271025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VTGN", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.135209", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CGEN", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYH", "relevance_score": "0.057559", "ticker_sentiment_score": "0.231004", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QD", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.082299", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "STX", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.157607", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TKLF", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.082957", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDC", "relevance_score": "0.057559", "ticker_sentiment_score": "0.026519", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXL", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.13598", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.086245", "ticker_sentiment_score": "-0.079107", "ticker_sentiment_label": "Neutral"}, {"ticker": "HKD", "relevance_score": "0.086245", "ticker_sentiment_score": "0.017717", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMN", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIVB", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.166994", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HCA", "relevance_score": "0.086245", "ticker_sentiment_score": "0.217893", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SANA", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILAG", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.028798", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVLU", "relevance_score": "0.086245", "ticker_sentiment_score": "-0.191908", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SXTC", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVB", "relevance_score": "0.057559", "ticker_sentiment_score": "0.271025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SBTX", "relevance_score": "0.086245", "ticker_sentiment_score": "-0.181524", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "REVB", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NLSP", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBLA", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MHUA", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGY", "relevance_score": "0.086245", "ticker_sentiment_score": "0.093544", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.273027", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KPRX", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.034114", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVTL", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.057559", "ticker_sentiment_score": "0.211", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDIA", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NEXI", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFH", "relevance_score": "0.057559", "ticker_sentiment_score": "0.271025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "THC", "relevance_score": "0.086245", "ticker_sentiment_score": "0.228297", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SUPV", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HNGR", "relevance_score": "0.057559", "ticker_sentiment_score": "0.249011", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PLXP", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TBLT", "relevance_score": "0.086245", "ticker_sentiment_score": "0.093544", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RMTI", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.35014", "ticker_sentiment_label": "Bearish"}, {"ticker": "PINS", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.022096", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAX", "relevance_score": "0.086245", "ticker_sentiment_score": "0.075179", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LMNL", "relevance_score": "0.086245", "ticker_sentiment_score": "-0.195024", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NEXPF", "relevance_score": "0.028798", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCTY", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.191999", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PRPH", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GFAI", "relevance_score": "0.086245", "ticker_sentiment_score": "0.083339", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAP", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.064049", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCTK", "relevance_score": "0.057559", "ticker_sentiment_score": "0.271025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SCHL", "relevance_score": "0.057559", "ticker_sentiment_score": "0.206", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMRS", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PIK", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CLNN", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TROO", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFIE", "relevance_score": "0.057559", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAOS", "relevance_score": "0.057559", "ticker_sentiment_score": "0.061912", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.010058", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDY", "relevance_score": "0.057559", "ticker_sentiment_score": "-0.300055", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Hot Penny Stocks to Buy Right Now? Check These 3 Out", "url": "https://pennystocks.com/featured/2022/06/24/hot-penny-stocks-buy-now-check-3-out/", "time_published": "20220624T194307", "authors": [], "summary": "Over the last few days, we've seen sizable bullish sentiment in the stock market with penny stocks and blue chips. While this is a welcomed advancement following weeks of bearish trading patterns, investors need to stay on their toes.", "banner_image": "https://pennystocks.com/wp-content/uploads/2022/06/Penny_Stocks_to_Watch_Redhill-Bio-RDHL-Stock-Chart.jpg", "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999499"}, {"topic": "Earnings", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.085511, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.208106", "ticker_sentiment_score": "-0.084154", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix gets up to $25.3 mln contract from Canada for smallpox drug", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/chimerix-gets-up-253-mln-contract-canada-smallpox-drug-2022-06-24/", "time_published": "20220624T145000", "authors": ["Reuters"], "summary": "Two samples of suspected cases of monkeypox go through a process of nucleic acid extraction as they get tested at a microbiology lab at La Paz Hospital in Madrid, Spain, June 1, 2022. REUTERS/Susana Vera", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/ZGWRQRCGWNJE5BBTHDI4YPKJ3M.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.015058, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.515636", "ticker_sentiment_score": "0.015058", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.184316", "ticker_sentiment_score": "0.018958", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada", "url": "https://www.benzinga.com/pressreleases/22/06/g27843390/chimerix-announces-tembexa-procurement-agreement-for-approximately-25-3-million-with-public-health", "time_published": "20220624T140616", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., June 24, 2022 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced Public Health Agency of Canada awarded Chimerix a contract up ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.316726"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.000366, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.642555", "ticker_sentiment_score": "0.011211", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.081441", "ticker_sentiment_score": "0.012023", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada", "url": "https://www.globenewswire.com/news-release/2022/06/24/2468864/25619/en/Chimerix-Announces-TEMBEXA-Procurement-Agreement-for-Approximately-25-3-Million-with-Public-Health-Agency-of-Canada.html", "time_published": "20220624T140600", "authors": ["Chimerix", "Inc."], "summary": "DURHAM, N.C., June 24, 2022 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced Public Health Agency of Canada awarded Chimerix a ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/9b5bc625-104d-4a8b-9efc-877699d633d4?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Earnings", "relevance_score": "0.316726"}], "overall_sentiment_score": -0.112946, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.557561", "ticker_sentiment_score": "-0.112946", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.051035", "ticker_sentiment_score": "0.012928", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement", "url": "https://www.benzinga.com/pressreleases/22/06/g27827658/chimerix-announces-9-3-million-international-tembexa-procurement-agreement", "time_published": "20220623T131500", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., June 23, 2022 ( GLOBE NEWSWIRE ) -- Chimerix CMRX, a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced a $9.3 million agreement to procure TEMBEXA\u00ae ( brincidofovir ) ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}, {"topic": "Earnings", "relevance_score": "0.316726"}], "overall_sentiment_score": -0.148331, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.565345", "ticker_sentiment_score": "-0.145771", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.047921", "ticker_sentiment_score": "0.03377", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement", "url": "https://www.globenewswire.com/news-release/2022/06/23/2468094/25619/en/Chimerix-Announces-9-3-Million-International-TEMBEXA-Procurement-Agreement.html", "time_published": "20220623T131500", "authors": ["Chimerix", "Inc."], "summary": "DURHAM, N.C., June 23, 2022 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced a $9.3 million agreement to procure TEMBEXA\u00ae ( ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/9b5bc625-104d-4a8b-9efc-877699d633d4?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Earnings", "relevance_score": "0.316726"}], "overall_sentiment_score": -0.106252, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.544775", "ticker_sentiment_score": "-0.106252", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.049619", "ticker_sentiment_score": "0.050314", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article", "time_published": "20220613T161842", "authors": ["Benzinga Insights"], "summary": "During Monday's trading, 1214 companies set new 52-week lows. The largest company by market cap to set a new 52-week low was Microsoft MSFT. Quoin Pharmaceuticals QNRX was the smallest company by market cap to set a new 52-week low. DexCom DXCM's stock fell the most, as it traded down 76.5% to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_10371.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.018781, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CNTG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027909", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.009789", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000109", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.394081", "ticker_sentiment_label": "Bearish"}, {"ticker": "EXAS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006089", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002333", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTGN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005659", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006147", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008999", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.04494", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027053", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLW", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004474", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017209", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.002683", "ticker_sentiment_score": "0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.037999", "ticker_sentiment_label": "Neutral"}, {"ticker": "COUP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009823", "ticker_sentiment_label": "Neutral"}, {"ticker": "FARO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002432", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.019024", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTWO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.314549", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VIRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.229754", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BOXL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030487", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00374", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005022", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007708", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.016249", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005408", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUBE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001207", "ticker_sentiment_label": "Neutral"}, {"ticker": "AL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001131", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008257", "ticker_sentiment_label": "Neutral"}, {"ticker": "AP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004327", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008806", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.342178", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SSNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004169", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSEC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006633", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.02233", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEGH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006247", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTCW", "relevance_score": "0.002683", "ticker_sentiment_score": "0.0055", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001487", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011287", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001164", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLOK", "relevance_score": "0.005366", "ticker_sentiment_score": "7.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009324", "ticker_sentiment_label": "Neutral"}, {"ticker": "SES", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.021897", "ticker_sentiment_label": "Neutral"}, {"ticker": "VITL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000388", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003981", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.041898", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008576", "ticker_sentiment_label": "Neutral"}, {"ticker": "F", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010108", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.003565", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004917", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00219", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002581", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARCE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001268", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAVM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.037181", "ticker_sentiment_label": "Neutral"}, {"ticker": "THC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001967", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.039444", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000453", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWBC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002907", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACEL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009212", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZTS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005325", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.006309", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004249", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACB", "relevance_score": "0.005366", "ticker_sentiment_score": "-9e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.177272", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HQI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.028836", "ticker_sentiment_label": "Neutral"}, {"ticker": "BXMT", "relevance_score": "0.005366", "ticker_sentiment_score": "3.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001269", "ticker_sentiment_label": "Neutral"}, {"ticker": "JZXN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017992", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFGP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002325", "ticker_sentiment_label": "Neutral"}, {"ticker": "UGRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007002", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005908", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFSL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010451", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00184", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.197234", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.107514", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005633", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006145", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-9.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002013", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALXO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001482", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBNY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013582", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005157", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00131", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003307", "ticker_sentiment_label": "Neutral"}, {"ticker": "DD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000957", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002541", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014392", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001189", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011785", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.023485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.017301", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00021", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.47679", "ticker_sentiment_label": "Bearish"}, {"ticker": "GPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006787", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.016373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITW", "relevance_score": "0.005366", "ticker_sentiment_score": "0.015548", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZUL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.018071", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.03994", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007245", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYMT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007944", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005756", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENSC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.174993", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INFY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010375", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004067", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002323", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNDM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001063", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010741", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009463", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWMN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.015382", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDWR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.080194", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0088", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001972", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009282", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.022412", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008283", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000178", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002374", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006113", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00144", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002664", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000298", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.371182", "ticker_sentiment_label": "Bearish"}, {"ticker": "SIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.014158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.019862", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOYU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013209", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPRO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.104865", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007895", "ticker_sentiment_label": "Neutral"}, {"ticker": "FN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000843", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNB", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.008789", "ticker_sentiment_label": "Neutral"}, {"ticker": "STWD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002531", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.006072", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNGX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.049879", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.038976", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0102", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.044669", "ticker_sentiment_label": "Neutral"}, {"ticker": "CION", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0047", "ticker_sentiment_label": "Neutral"}, {"ticker": "GE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.346341", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCCC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001494", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000903", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003168", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBLU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005037", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003672", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.242942", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SSSS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000192", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008319", "ticker_sentiment_label": "Neutral"}, {"ticker": "GP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004607", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLZE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004558", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.005083", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013405", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003042", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013694", "ticker_sentiment_label": "Neutral"}, {"ticker": "VBIV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002076", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003243", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.050455", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000857", "ticker_sentiment_label": "Neutral"}, {"ticker": "HA", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.003169", "ticker_sentiment_label": "Neutral"}, {"ticker": "RICK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003331", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008186", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVCM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012919", "ticker_sentiment_label": "Neutral"}, {"ticker": "UMBF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.033109", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENTG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003676", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIII", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009225", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007906", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00294", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003236", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.073546", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00055", "ticker_sentiment_label": "Neutral"}, {"ticker": "OXLC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003855", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.010731", "ticker_sentiment_score": "0.056798", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOUR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014221", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006197", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.212204", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UPH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001906", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGHT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007331", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.014763", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003835", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013876", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001742", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCBO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002769", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013135", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000152", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003007", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006871", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSKEF", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.001137", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011391", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002906", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00204", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003766", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGAL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.019917", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.002683", "ticker_sentiment_score": "0.0045", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002285", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDUP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002977", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030157", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01473", "ticker_sentiment_label": "Neutral"}, {"ticker": "OEG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003312", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIMV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001842", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTOL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006181", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005648", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013855", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005093", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.041687", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01318", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERJ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0094", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBGI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006823", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001436", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVER", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRCT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00895", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.018778", "ticker_sentiment_score": "0.001179", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008479", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004566", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003902", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008305", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.010138", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00371", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004256", "ticker_sentiment_label": "Neutral"}, {"ticker": "URI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002609", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.005366", "ticker_sentiment_score": "0.0051", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTCT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000932", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003728", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017667", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002149", "ticker_sentiment_label": "Neutral"}, {"ticker": "KB", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.010525", "ticker_sentiment_label": "Neutral"}, {"ticker": "GWH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006451", "ticker_sentiment_label": "Neutral"}, {"ticker": "COF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000213", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBCI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005604", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008957", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBIO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005515", "ticker_sentiment_label": "Neutral"}, {"ticker": "SATL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006127", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUAD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.038077", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCFC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002964", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFRI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00759", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005261", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000143", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBTYA", "relevance_score": "0.002683", "ticker_sentiment_score": "0.001132", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOSS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01457", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMBIL", "relevance_score": "0.002683", "ticker_sentiment_score": "0.008572", "ticker_sentiment_label": "Neutral"}, {"ticker": "XYL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.055113", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001097", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001493", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006709", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01114", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.016704", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004563", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTMD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007197", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00283", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01399", "ticker_sentiment_label": "Neutral"}, {"ticker": "LE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.298506", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NEO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00126", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000582", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.005366", "ticker_sentiment_score": "0.034025", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014023", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBTX", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.172639", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005746", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.04368", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAW", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004566", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007224", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012256", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRAA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005135", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001664", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.020627", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPER", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013746", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013786", "ticker_sentiment_label": "Neutral"}, {"ticker": "NHTC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.026834", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006603", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002043", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013974", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRGV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030374", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.057433", "ticker_sentiment_label": "Neutral"}, {"ticker": "AME", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001235", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010887", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005912", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.021861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005292", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002632", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROVR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00612", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001002", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.276654", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UNIT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005813", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.035506", "ticker_sentiment_label": "Neutral"}, {"ticker": "YELL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.024766", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALBO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002894", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.011699", "ticker_sentiment_label": "Neutral"}, {"ticker": "MU", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011682", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORCL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007027", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010378", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001984", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVNO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007961", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.022522", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003053", "ticker_sentiment_label": "Neutral"}, {"ticker": "LESL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003861", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002341", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001654", "ticker_sentiment_label": "Neutral"}, {"ticker": "CENX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004993", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010093", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMRE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003212", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.003976", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017414", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001716", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.28098", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MGTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008235", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.024331", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRLD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.250534", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMCX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008317", "ticker_sentiment_label": "Neutral"}, {"ticker": "NN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.051327", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001001", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004653", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSEC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00902", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.015", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.136277", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPE", "relevance_score": "0.005366", "ticker_sentiment_score": "4e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.04472", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000672", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.006213", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009636", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000725", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTGX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009216", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006137", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017906", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002249", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPR", "relevance_score": "0.008048", "ticker_sentiment_score": "0.001455", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003319", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.282133", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LBPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005701", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTIS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002654", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.253696", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VLDR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.031864", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009077", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.005366", "ticker_sentiment_score": "0.010008", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRMK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007329", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002994", "ticker_sentiment_label": "Neutral"}, {"ticker": "PH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000858", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000173", "ticker_sentiment_label": "Neutral"}, {"ticker": "PK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.026715", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000458", "ticker_sentiment_label": "Neutral"}, {"ticker": "RUBY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00549", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTDR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.289087", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FXLV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000102", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNON", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.024476", "ticker_sentiment_label": "Neutral"}, {"ticker": "APO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005626", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIAV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000652", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLWS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005501", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.034935", "ticker_sentiment_label": "Neutral"}, {"ticker": "XSPA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003054", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.029459", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003869", "ticker_sentiment_label": "Neutral"}, {"ticker": "STM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.26252", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GSBD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005083", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030902", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00391", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012266", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUK", "relevance_score": "0.002683", "ticker_sentiment_score": "0.029025", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZENV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003257", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003011", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003282", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005966", "ticker_sentiment_label": "Neutral"}, {"ticker": "QS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003825", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLAB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.065602", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006692", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGNY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.033419", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUNE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027877", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008994", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013387", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORGO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002621", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000994", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005841", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRDS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007866", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLYM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.17614", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SNTI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008436", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWOD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001806", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000191", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007939", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRSK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001025", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTFT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00147", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006956", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.044451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002691", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014395", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.05491", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.035328", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.014448", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000107", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLYW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.280495", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TXN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004765", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002255", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00155", "ticker_sentiment_label": "Neutral"}, {"ticker": "FITB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00525", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006384", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACVA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.167193", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.023907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.101005", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.426684", "ticker_sentiment_label": "Bearish"}, {"ticker": "NLY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.018267", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002427", "ticker_sentiment_label": "Neutral"}, {"ticker": "KFY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013786", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002735", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.050893", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002399", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000644", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFET", "relevance_score": "0.005366", "ticker_sentiment_score": "0.0403", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01828", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000404", "ticker_sentiment_label": "Neutral"}, {"ticker": "SILC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003704", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000847", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004694", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003456", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPEN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005675", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATXS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006552", "ticker_sentiment_label": "Neutral"}, {"ticker": "VATE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004868", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZNP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001317", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.03375", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015914", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPMC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013229", "ticker_sentiment_label": "Neutral"}, {"ticker": "DESP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003244", "ticker_sentiment_label": "Neutral"}, {"ticker": "VORB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011817", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01245", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMWB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009317", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015156", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00235", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMKR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002277", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017984", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008789", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.046567", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008791", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.028722", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007241", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRON", "relevance_score": "0.005366", "ticker_sentiment_score": "0.023575", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.040438", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00893", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMFC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.02795", "ticker_sentiment_label": "Neutral"}, {"ticker": "UP", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.017094", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005889", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLDX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003648", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003256", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015322", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003469", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005381", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003888", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002958", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007964", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000464", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNHI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014746", "ticker_sentiment_label": "Neutral"}, {"ticker": "KORE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.017331", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000409", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006232", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDSN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014258", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.021784", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007028", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBDC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007026", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004191", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVTC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001847", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01029", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBLA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004869", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008775", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001806", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00297", "ticker_sentiment_label": "Neutral"}, {"ticker": "UHID", "relevance_score": "0.002683", "ticker_sentiment_score": "0.006598", "ticker_sentiment_label": "Neutral"}, {"ticker": "POET", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000856", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWIN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.09399", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003517", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMBK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009154", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000764", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARWR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000431", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00341", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006057", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005028", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.036964", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011918", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIFE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.106035", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01838", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIPO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.018148", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006823", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006081", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLYB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000186", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004032", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYN", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.004229", "ticker_sentiment_label": "Neutral"}, {"ticker": "STER", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.037725", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUMU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01307", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014019", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004274", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.002683", "ticker_sentiment_score": "0.035061", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.410902", "ticker_sentiment_label": "Bearish"}, {"ticker": "BZH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011111", "ticker_sentiment_label": "Neutral"}, {"ticker": "OST", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003768", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007762", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002945", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005683", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRHC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.016485", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQIX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000866", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008322", "ticker_sentiment_label": "Neutral"}, {"ticker": "REKR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014413", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001112", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.047866", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.010639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZFD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011203", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004841", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRMW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000353", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWKS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.022588", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBWI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.060782", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.177137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KLR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006762", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.034866", "ticker_sentiment_score": "0.006675", "ticker_sentiment_label": "Neutral"}, {"ticker": "FERG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.214254", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MPW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000688", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLED", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009965", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVPH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.016238", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBTX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.043124", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETZ", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003573", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.032893", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000512", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006642", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001026", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017825", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSBK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.064589", "ticker_sentiment_label": "Neutral"}, {"ticker": "TY-P", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.006567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.010323", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.079529", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003508", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.092696", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.030029", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHPW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.031876", "ticker_sentiment_label": "Neutral"}, {"ticker": "HHC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.012851", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUMA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.292681", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FRME", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002489", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006409", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00436", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGTI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009179", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010966", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002149", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESRT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003209", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006306", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01173", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBNC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.038416", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRUS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003047", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANSS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007534", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNAZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000638", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027316", "ticker_sentiment_label": "Neutral"}, {"ticker": "NATR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.016507", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCMG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00216", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00426", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBGI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003944", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00816", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITE", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.147209", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBP", "relevance_score": "0.002683", "ticker_sentiment_score": "5.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.285853", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DBRG-P-I", "relevance_score": "0.002683", "ticker_sentiment_score": "0.011535", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDSB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005046", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005913", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000958", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.020239", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.022321", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00424", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003463", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003073", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005686", "ticker_sentiment_label": "Neutral"}, {"ticker": "JYNT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.058627", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009997", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004248", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.020459", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002649", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAVI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000292", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001094", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVBF", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001092", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007576", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001048", "ticker_sentiment_label": "Neutral"}, {"ticker": "VFF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009866", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.457779", "ticker_sentiment_label": "Bearish"}, {"ticker": "VSAT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001534", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011298", "ticker_sentiment_label": "Neutral"}, {"ticker": "THRY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007243", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001505", "ticker_sentiment_label": "Neutral"}, {"ticker": "THRX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001096", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.217102", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BLND", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006675", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENIA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001103", "ticker_sentiment_label": "Neutral"}, {"ticker": "GIB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000218", "ticker_sentiment_label": "Neutral"}, {"ticker": "DATS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000151", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001912", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITIC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015091", "ticker_sentiment_label": "Neutral"}, {"ticker": "GIL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009558", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.012286", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEAV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007896", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLLS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007774", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQOS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012653", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.076716", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFWM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004455", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011165", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPTN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001029", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELEV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006705", "ticker_sentiment_label": "Neutral"}, {"ticker": "TACT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.287375", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TREE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006545", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006116", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGRY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011411", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASAN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011856", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001405", "ticker_sentiment_label": "Neutral"}, {"ticker": "OZK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000702", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMDA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01837", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000777", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007437", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.022206", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNTV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.185813", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006554", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014567", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGFV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.033718", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.021183", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.072571", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRNQ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005018", "ticker_sentiment_label": "Neutral"}, {"ticker": "JELD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.245399", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VKTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.033916", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGIO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.019831", "ticker_sentiment_label": "Neutral"}, {"ticker": "LJPC", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.048285", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.033555", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLAY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005318", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIGI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000392", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMRN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001003", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001128", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTEX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006763", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006605", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.062872", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.002683", "ticker_sentiment_score": "0.047017", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001794", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.040702", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000426", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.310839", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NYT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027556", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.254871", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003342", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRMN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003882", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDAY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.034094", "ticker_sentiment_label": "Neutral"}, {"ticker": "AINV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008496", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002725", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.531702", "ticker_sentiment_label": "Bearish"}, {"ticker": "KTB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004746", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012133", "ticker_sentiment_label": "Neutral"}, {"ticker": "USFD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005066", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRNA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007569", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAIN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00738", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:GBP", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.037725", "ticker_sentiment_label": "Neutral"}]}, {"title": "POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING", "url": "https://www.prnewswire.com/news-releases/positive-data-for-paxalisib-in-two-childhood-brain-cancers-presented-at-20th-ispno-annual-meeting-301565498.html", "time_published": "20220613T110000", "authors": ["Kazia Therapeutics Limited"], "summary": "SYDNEY, June 13, 2022 /PRNewswire/ -- Kazia Therapeutics Limited ( NASDAQ: KZIA. ASX: KZA ) , an oncology-focused drug development company, is pleased to announce the presentation of new data regarding the activity of paxalisib in two forms of childhood brain cancer with poor prognosis and ...", "banner_image": "https://mma.prnewswire.com/media/766762/Kazia_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.041121, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KZIA", "relevance_score": "0.123178", "ticker_sentiment_score": "0.123835", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.03091", "ticker_sentiment_score": "0.003754", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.03091", "ticker_sentiment_score": "0.009322", "ticker_sentiment_label": "Neutral"}]}, {"title": "21 Americans Infected With Monkeypox, C.D.C. Reports", "url": "https://www.nytimes.com/2022/06/03/health/monkeypox-vaccine-treatments.html", "time_published": "20220603T180204", "authors": [], "summary": "As the number of cases outside Africa approaches 800, governments are scrambling for a limited pool of vaccines and treatments with unclear effectiveness.", "banner_image": "https://static01.nyt.com/images/2022/06/02/science/00drugs1/merlin_207444036_e151859e-38d2-4f5e-9a0f-4fb360db046a-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "Business", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.162377, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "SIGA", "relevance_score": "0.021145", "ticker_sentiment_score": "0.117209", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.042275", "ticker_sentiment_score": "-0.163661", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "EU drugs watchdog in talks with Bavarian Nordic over wider use of smallpox vaccine", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drugs-watchdog-talks-with-bavarian-nordic-over-wider-use-smallpox-vaccine-2022-06-02/", "time_published": "20220602T134400", "authors": ["Reuters"], "summary": "An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. The company, headquartered in Denmark, is the only one in the world to have approval for a smallpox vaccine called Jynneos in the U.S. and Imvanex in Europe, ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/VXZ3Q3M5YBMMVEGX44AFB74UI4.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.019717, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.157175", "ticker_sentiment_score": "0.019717", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Penny Stocks To Watch As Monkeypox Cases Rise", "url": "https://pennystocks.com/featured/2022/06/01/top-penny-stocks-to-watch-as-monkeypox-cases-rise/", "time_published": "20220602T000901", "authors": [], "summary": "The latest outbreak of monkeypox has some scratching their heads. What more can 2022 bring to the market? We've seen a stock market crash, the hopeful recovery from COVID-19, record inflation, rising rates, and now this. But it has placed some penny stocks in focus.", "banner_image": null, "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999998"}], "overall_sentiment_score": -0.035281, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TNXP", "relevance_score": "0.101869", "ticker_sentiment_score": "-0.043635", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.101869", "ticker_sentiment_score": "-0.027116", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.101869", "ticker_sentiment_score": "0.016506", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.068016", "ticker_sentiment_score": "0.017426", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix to Present at Jefferies Global Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2022/06/01/2454754/25619/en/Chimerix-to-Present-at-Jefferies-Global-Healthcare-Conference.html", "time_published": "20220601T203000", "authors": ["Inc.", "Chimerix"], "summary": "DURHAM, N.C., June 01, 2022 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, Chief Executive Officer, will p", "banner_image": "https://ml.globenewswire.com/Resource/Download/9b5bc625-104d-4a8b-9efc-877699d633d4?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.063411, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.499789", "ticker_sentiment_score": "0.063411", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here Are The Companies That Could Profit As Governments Scramble To Secure Monkeypox Treatments And Vaccines", "url": "https://www.forbes.com/sites/roberthart/2022/05/28/here-are-the-companies-that-could-profit-as-governments-scramble-to-secure-monkeypox-treatments-and-vaccines/", "time_published": "20220528T110000", "authors": ["Robert Hart"], "summary": "There are few treatments or vaccines authorized against monkeypox but officials and experts say those developed for smallpox are likely to be effective.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve//6291364a838fba7201efe933/0x0.jpg?format=jpg&crop=3000,1999,x0,y181,safe&width=1200", "source": "Forbes", "category_within_source": "Business", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.026506, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.036767", "ticker_sentiment_score": "-0.080117", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.036767", "ticker_sentiment_score": "0.06245", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.036767", "ticker_sentiment_score": "0.06245", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.073456", "ticker_sentiment_score": "0.06245", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.036767", "ticker_sentiment_score": "0.06245", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Upgrades Chimerix  ( NASDAQ:CMRX )  to \"Hold\"", "url": "https://www.etfdailynews.com/2022/05/28/stocknews-com-upgrades-chimerix-nasdaqcmrx-to-hold/", "time_published": "20220528T021847", "authors": ["MarketBeat News"], "summary": "Chimerix ( NASDAQ:CMRX - Get Rating ) was upgraded by StockNews.com from a \"sell\" rating to a \"hold\" rating in a research report issued on Friday. Several other research firms also recently commented on CMRX. Wedbush reiterated an \"outperform\" rating on shares of Chimerix in a research report ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/chimerix-inc-logo.JPG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999922"}], "overall_sentiment_score": 0.016627, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MCQEF", "relevance_score": "0.061112", "ticker_sentiment_score": "0.018305", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.892606", "ticker_sentiment_score": "0.016627", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( NASDAQ:CMRX )  Rating Increased to Hold at StockNews.com", "url": "https://www.defenseworld.net/2022/05/28/chimerix-nasdaqcmrx-rating-increased-to-hold-at-stocknews-com.html", "time_published": "20220528T021841", "authors": ["admin"], "summary": "Chimerix ( NASDAQ:CMRX - Get Rating ) was upgraded by StockNews.com from a \"sell\" rating to a \"hold\" rating in a research note issued to investors on Friday. Other equities research analysts have also recently issued reports about the company.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/chimerix-inc-logo.JPG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99977"}], "overall_sentiment_score": 0.009604, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MCQEF", "relevance_score": "0.061221", "ticker_sentiment_score": "0.017245", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.855516", "ticker_sentiment_score": "0.009604", "ticker_sentiment_label": "Neutral"}]}, {"title": "Explainer: What vaccines, treatments do we have to combat monkeypox?", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/what-vaccines-treatments-do-we-have-combat-monkeypox-2022-05-25/", "time_published": "20220525T110000", "authors": ["Natalie Grover"], "summary": "A section of skin tissue, harvested from a lesion on the skin of a monkey, that had been infected with monkeypox virus, is seen at 50X magnification on day four of rash development in 1968. CDC/Handout via REUTERS.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/FAOVV7B6ZFLWDHFDKHOGC6SMNA.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.014513, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SIGA", "relevance_score": "0.04877", "ticker_sentiment_score": "0.046702", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.04877", "ticker_sentiment_score": "-0.116775", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.04877", "ticker_sentiment_score": "0.000104", "ticker_sentiment_label": "Neutral"}]}, {"title": "71 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/05/27388332/71-biggest-movers-from-yesterday", "time_published": "20220525T083352", "authors": ["Lisa Levin"], "summary": "Gainers CynergisTek, Inc. ( NYSE: CTEK ) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million. Better Therapeutics, Inc. ( NASDAQ: BTTX ) jumped 69.8% to settle at $2.19 after dro", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/25/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.995921"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.019034, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SKY", "relevance_score": "0.085213", "ticker_sentiment_score": "0.094079", "ticker_sentiment_label": "Neutral"}, {"ticker": "TELA", "relevance_score": "0.085213", "ticker_sentiment_score": "0.00153", "ticker_sentiment_label": "Neutral"}, {"ticker": "VGFC", "relevance_score": "0.056869", "ticker_sentiment_score": "0.515572", "ticker_sentiment_label": "Bullish"}, {"ticker": "CANG", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.001436", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOBR", "relevance_score": "0.056869", "ticker_sentiment_score": "0.14397", "ticker_sentiment_label": "Neutral"}, {"ticker": "FEMY", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.098445", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMBL", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.049222", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRGE", "relevance_score": "0.085213", "ticker_sentiment_score": "0.0166", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDH", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.000851", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.1141", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.000563", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUR", "relevance_score": "0.056869", "ticker_sentiment_score": "0.001895", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.056869", "ticker_sentiment_score": "0.00216", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSR", "relevance_score": "0.085213", "ticker_sentiment_score": "0.026326", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.030821", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.056869", "ticker_sentiment_score": "0.011057", "ticker_sentiment_label": "Neutral"}, {"ticker": "DADA", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.005631", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEDU", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.032063", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.056869", "ticker_sentiment_score": "0.004977", "ticker_sentiment_label": "Neutral"}, {"ticker": "PUBM", "relevance_score": "0.085213", "ticker_sentiment_score": "0.083408", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.056869", "ticker_sentiment_score": "0.00031", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMM", "relevance_score": "0.056869", "ticker_sentiment_score": "0.003287", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANF", "relevance_score": "0.056869", "ticker_sentiment_score": "0.000137", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.085213", "ticker_sentiment_score": "0.000292", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRCT", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.530084", "ticker_sentiment_label": "Bearish"}, {"ticker": "ROKU", "relevance_score": "0.056869", "ticker_sentiment_score": "0.000677", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.028333", "ticker_sentiment_label": "Neutral"}, {"ticker": "WKME", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.011805", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.056869", "ticker_sentiment_score": "0.000116", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.056869", "ticker_sentiment_score": "0.001712", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.028453", "ticker_sentiment_score": "-0.028333", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTTX", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.021113", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMT", "relevance_score": "0.056869", "ticker_sentiment_score": "0.013806", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZTEK", "relevance_score": "0.056869", "ticker_sentiment_score": "0.012946", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.056869", "ticker_sentiment_score": "0.005159", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUBT", "relevance_score": "0.056869", "ticker_sentiment_score": "0.01909", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.388881", "ticker_sentiment_label": "Bearish"}, {"ticker": "EXPR", "relevance_score": "0.085213", "ticker_sentiment_score": "0.007637", "ticker_sentiment_label": "Neutral"}, {"ticker": "OKYO", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.010234", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMB", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.003621", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.085213", "ticker_sentiment_score": "0.004845", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.126538", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.003419", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSC", "relevance_score": "0.056869", "ticker_sentiment_score": "0.003571", "ticker_sentiment_label": "Neutral"}, {"ticker": "APSG", "relevance_score": "0.056869", "ticker_sentiment_score": "0.000598", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQDA", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.083489", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPL", "relevance_score": "0.085213", "ticker_sentiment_score": "0.012228", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.056869", "ticker_sentiment_score": "0.004002", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFIX", "relevance_score": "0.056869", "ticker_sentiment_score": "0.000167", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFAI", "relevance_score": "0.056869", "ticker_sentiment_score": "0.005003", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALA", "relevance_score": "0.085213", "ticker_sentiment_score": "0.007943", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRC", "relevance_score": "0.085213", "ticker_sentiment_score": "0.051411", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMBIL", "relevance_score": "0.056869", "ticker_sentiment_score": "0.002706", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESEA", "relevance_score": "0.056869", "ticker_sentiment_score": "0.044309", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAP", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.009169", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUTR", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.075898", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATTO", "relevance_score": "0.085213", "ticker_sentiment_score": "2.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMNDF", "relevance_score": "0.028453", "ticker_sentiment_score": "0.051411", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEON", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.027817", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAO", "relevance_score": "0.056869", "ticker_sentiment_score": "0.001487", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAD", "relevance_score": "0.056869", "ticker_sentiment_score": "0.001073", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOTK", "relevance_score": "0.085213", "ticker_sentiment_score": "0.003736", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSCR", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.020766", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAI", "relevance_score": "0.085213", "ticker_sentiment_score": "-0.014635", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.028453", "ticker_sentiment_score": "-0.071142", "ticker_sentiment_label": "Neutral"}, {"ticker": "XFOR", "relevance_score": "0.056869", "ticker_sentiment_score": "0.005906", "ticker_sentiment_label": "Neutral"}, {"ticker": "APCX", "relevance_score": "0.056869", "ticker_sentiment_score": "0.0013", "ticker_sentiment_label": "Neutral"}, {"ticker": "API", "relevance_score": "0.056869", "ticker_sentiment_score": "-0.071142", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:IOP", "relevance_score": "0.028453", "ticker_sentiment_score": "-0.000851", "ticker_sentiment_label": "Neutral"}]}, {"title": "12 Health Care Stocks Moving In Tuesday's Intraday Session", "url": "https://www.benzinga.com/trading-ideas/movers/22/05/27378950/12-health-care-stocks-moving-in-tuesdays-intraday-session", "time_published": "20220524T183635", "authors": ["Benzinga Insights"], "summary": "Gainers BIMI Intl Medical ( NASDAQ:BIMI ) shares moved upwards by 37.2% to $0.83 during Tuesday's regular session. Trading volume for BIMI Intl Medical's stock is 34.1 million as of 13:30 EST. This is 19077.6% of its average full-day volume over the last 100 days. The market value of their outstan", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_9275.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.910869"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.008164, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LQDA", "relevance_score": "0.140157", "ticker_sentiment_score": "0.003514", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUWE", "relevance_score": "0.140157", "ticker_sentiment_score": "0.003238", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.140157", "ticker_sentiment_score": "-0.000252", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMB", "relevance_score": "0.140157", "ticker_sentiment_score": "0.000276", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALA", "relevance_score": "0.140157", "ticker_sentiment_score": "0.00093", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTTX", "relevance_score": "0.140157", "ticker_sentiment_score": "0.005904", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.140157", "ticker_sentiment_score": "0.001748", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.140157", "ticker_sentiment_score": "-0.002666", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.208884", "ticker_sentiment_score": "0.000966", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.140157", "ticker_sentiment_score": "0.001614", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.140157", "ticker_sentiment_score": "-0.010401", "ticker_sentiment_label": "Neutral"}]}, {"title": "50 Stocks Moving In Tuesday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/05/27376653/50-stocks-moving-in-tuesdays-mid-day-session", "time_published": "20220524T161041", "authors": ["Lisa Levin"], "summary": "Gainers CynergisTek, Inc. ( NYSE: CTEK ) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million. SciSparc Ltd. ( NASDAQ: SPRC ) gained 62% to $3.70. SciSparc disclosed positive safety profile results from its", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/24/mid-day_movers_image.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.94762"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.980509"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.030066, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "WKME", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.006587", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.000158", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.081844", "ticker_sentiment_score": "0.000677", "ticker_sentiment_label": "Neutral"}, {"ticker": "CANG", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.016397", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTTX", "relevance_score": "0.122497", "ticker_sentiment_score": "-0.008562", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMT", "relevance_score": "0.081844", "ticker_sentiment_score": "0.009418", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.081844", "ticker_sentiment_score": "0.001387", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.081844", "ticker_sentiment_score": "0.001082", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUBT", "relevance_score": "0.081844", "ticker_sentiment_score": "0.008316", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.401269", "ticker_sentiment_label": "Bearish"}, {"ticker": "EXPR", "relevance_score": "0.122497", "ticker_sentiment_score": "0.005353", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDH", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.007341", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.122497", "ticker_sentiment_score": "-0.157067", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INMB", "relevance_score": "0.081844", "ticker_sentiment_score": "0.006226", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.020464", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBIO", "relevance_score": "0.122497", "ticker_sentiment_score": "0.0052", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.224911", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PRPL", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.001892", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSC", "relevance_score": "0.081844", "ticker_sentiment_score": "0.000701", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQDA", "relevance_score": "0.122497", "ticker_sentiment_score": "-0.07656", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.081844", "ticker_sentiment_score": "3.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSR", "relevance_score": "0.122497", "ticker_sentiment_score": "0.028861", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.011951", "ticker_sentiment_label": "Neutral"}, {"ticker": "DADA", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.003347", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFAI", "relevance_score": "0.081844", "ticker_sentiment_score": "0.001427", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALA", "relevance_score": "0.122497", "ticker_sentiment_score": "0.00523", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRC", "relevance_score": "0.122497", "ticker_sentiment_score": "0.088607", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESEA", "relevance_score": "0.081844", "ticker_sentiment_score": "0.027865", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAP", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.031484", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.081844", "ticker_sentiment_score": "0.003394", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.081844", "ticker_sentiment_score": "0.000432", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMNDF", "relevance_score": "0.040976", "ticker_sentiment_score": "0.088607", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEON", "relevance_score": "0.122497", "ticker_sentiment_score": "-0.034682", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOTK", "relevance_score": "0.122497", "ticker_sentiment_score": "0.003018", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSCR", "relevance_score": "0.122497", "ticker_sentiment_score": "-0.009639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAI", "relevance_score": "0.122497", "ticker_sentiment_score": "-0.014024", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.040976", "ticker_sentiment_score": "-0.105957", "ticker_sentiment_label": "Neutral"}, {"ticker": "XFOR", "relevance_score": "0.081844", "ticker_sentiment_score": "0.002073", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMM", "relevance_score": "0.081844", "ticker_sentiment_score": "0.001369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANF", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.109311", "ticker_sentiment_label": "Neutral"}, {"ticker": "APCX", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.000693", "ticker_sentiment_label": "Neutral"}, {"ticker": "API", "relevance_score": "0.081844", "ticker_sentiment_score": "-0.105957", "ticker_sentiment_label": "Neutral"}, {"ticker": "XAIR", "relevance_score": "0.122497", "ticker_sentiment_score": "0.035618", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIMI", "relevance_score": "0.081844", "ticker_sentiment_score": "3.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.122497", "ticker_sentiment_score": "-0.001145", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:IOP", "relevance_score": "0.040976", "ticker_sentiment_score": "-0.007341", "ticker_sentiment_label": "Neutral"}]}, {"title": "Are These 4 Stocks Smart Buys With the Monkeypox Outbreak?", "url": "https://www.fool.com/investing/2022/05/24/are-these-4-stocks-smart-buys-with-the-monkeypox-o/", "time_published": "20220524T095500", "authors": ["Keith Speights"], "summary": "The monkeypox opportunity could already be baked into the prices of these stocks.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F681015%2Fmonkeypox-vaccine.jpg&w=700&op=resize", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.071521, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SIGA", "relevance_score": "0.260768", "ticker_sentiment_score": "-0.090019", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVNKF", "relevance_score": "0.066322", "ticker_sentiment_score": "0.233072", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMRX", "relevance_score": "0.322655", "ticker_sentiment_score": "0.085917", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.260768", "ticker_sentiment_score": "-0.105118", "ticker_sentiment_label": "Neutral"}]}, {"title": "Clusters of monkeypox cases are driving up stock prices for some companies", "url": "https://www.marketwatch.com/story/clusters-of-monkeypox-cases-are-driving-up-stock-prices-for-some-companies-11653335587", "time_published": "20220523T195300", "authors": ["Jaimy Lee"], "summary": "Concern about monkeypox has sent shares of several vaccine and drug companies soaring.", "banner_image": "https://images.mktw.net/im-549781/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.154254, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "GOVX", "relevance_score": "0.092337", "ticker_sentiment_score": "-0.12754", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.092337", "ticker_sentiment_score": "-0.12754", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.092337", "ticker_sentiment_score": "-0.220696", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CMRX", "relevance_score": "0.092337", "ticker_sentiment_score": "-0.12754", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.092337", "ticker_sentiment_score": "-0.12754", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.092337", "ticker_sentiment_score": "-0.12754", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Emergent BioSolutions Stock Is Jumping Today", "url": "https://www.fool.com/investing/2022/05/23/why-emergent-biosolutions-stock-is-jumping-today/", "time_published": "20220523T153935", "authors": ["Keith Speights"], "summary": "Monkeypox concerns are boosting the stock.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F681511%2Fvaccine-being-given-to-teen-boy.jpg&w=700&op=resize", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.042552, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.515891", "ticker_sentiment_score": "0.00789", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.706081", "ticker_sentiment_score": "-0.036379", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Emergent Biosolutions Stock Is Rising Today", "url": "https://www.benzinga.com/markets/penny-stocks/22/05/27346864/why-emergent-biosolutions-stock-is-rising-today", "time_published": "20220523T134533", "authors": ["Adam Eckert"], "summary": "Emergent Biosolutions Inc ( NYSE: EBS ) shares are trading higher Monday amid increasing monkeypox concerns. A monkeypox outbreak has been reported in at least a dozen countries. There has been one confirmed case in the United States and at least one other case is suspected. President Biden on Su", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/23/laboratory-gd26a4cd27_1920.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": -0.085702, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.369319", "ticker_sentiment_score": "0.028243", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.529185", "ticker_sentiment_score": "-0.055116", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Stocks Under $3 Insiders Are Aggressively Buying", "url": "https://www.benzinga.com/trading-ideas/long-ideas/22/05/27345374/3-stocks-under-3-insiders-are-aggressively-buying", "time_published": "20220523T124607", "authors": ["Lisa Levin"], "summary": "US stock futures traded higher this morning on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a fa", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/23/image_2.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -2.4e-05, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VLCN", "relevance_score": "0.409004", "ticker_sentiment_score": "0.022411", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWRE", "relevance_score": "0.409004", "ticker_sentiment_score": "-0.001259", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.409004", "ticker_sentiment_score": "0.009599", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.106873", "ticker_sentiment_score": "0.04033", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Zacks Analyst Blog Highlights Emergent BioSolutions, Chimerix and SIGA Technologies", "url": "https://www.zacks.com/stock/news/1927663/the-zacks-analyst-blog-highlights-emergent-biosolutions-chimerix-and-siga-technologies", "time_published": "20220523T101400", "authors": ["Zacks Investment Research"], "summary": "Emergent BioSolutions, Chimerix and SIGA Technologies have been included in this Analyst Blog.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}], "overall_sentiment_score": -0.111973, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SIGA", "relevance_score": "0.340387", "ticker_sentiment_score": "-0.058048", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.131188", "ticker_sentiment_score": "0.009097", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.258854", "ticker_sentiment_score": "-0.082955", "ticker_sentiment_label": "Neutral"}]}, {"title": "24 Stocks Moving in Monday's Pre-Market Session", "url": "https://www.benzinga.com/news/22/05/27342423/24-stocks-moving-in-mondays-pre-market-session", "time_published": "20220523T101343", "authors": ["Lisa Levin"], "summary": "Gainers Genocea Biosciences, Inc. ( NASDAQ: GNCA ) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on Friday. Foresight Autonomous Holdings Ltd. ( NASDAQ: FRSX ) rose 24.8% to $0.97 in pre-market trading. SIGA Technologies, Inc. ( NASDAQ: SIGA ) rose 23.4% to $1", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/23/premkt_movers.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.910869"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.023908, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VMW", "relevance_score": "0.227361", "ticker_sentiment_score": "0.001284", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.152741", "ticker_sentiment_score": "0.001284", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLG", "relevance_score": "0.152741", "ticker_sentiment_score": "0.00288", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.152741", "ticker_sentiment_score": "2.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.152741", "ticker_sentiment_score": "0.003691", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRA", "relevance_score": "0.152741", "ticker_sentiment_score": "0.000931", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGEN", "relevance_score": "0.227361", "ticker_sentiment_score": "-0.003472", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.152741", "ticker_sentiment_score": "-0.000721", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.152741", "ticker_sentiment_score": "-0.379776", "ticker_sentiment_label": "Bearish"}, {"ticker": "INO", "relevance_score": "0.152741", "ticker_sentiment_score": "0.000412", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.152741", "ticker_sentiment_score": "0.002916", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.227361", "ticker_sentiment_score": "0.000486", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.152741", "ticker_sentiment_score": "0.000627", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRKA", "relevance_score": "0.227361", "ticker_sentiment_score": "5.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXL", "relevance_score": "0.152741", "ticker_sentiment_score": "0.002879", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.152741", "ticker_sentiment_score": "0.004587", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.152741", "ticker_sentiment_score": "0.010638", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.152741", "ticker_sentiment_score": "0.00252", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOEV", "relevance_score": "0.152741", "ticker_sentiment_score": "0.000588", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.152741", "ticker_sentiment_score": "0.000794", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLNO", "relevance_score": "0.227361", "ticker_sentiment_score": "0.000895", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.227361", "ticker_sentiment_score": "-0.006681", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Monkeypox Stocks That Soared Last Week", "url": "https://www.fool.com/investing/2022/05/23/3-monkeypox-stocks-that-soared-last-week/", "time_published": "20220523T091300", "authors": ["Cory Renauer"], "summary": "Fear of another viral outbreak is generating a lot of buzz around these three biotech stocks.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F681383%2Fsmart-investor-studying-stock-charts-getty.jpg&w=700&op=resize", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": -0.26269, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.05333", "ticker_sentiment_score": "-0.554367", "ticker_sentiment_label": "Bearish"}, {"ticker": "PFE", "relevance_score": "0.05333", "ticker_sentiment_score": "0.24866", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SIGA", "relevance_score": "0.261959", "ticker_sentiment_score": "-0.101121", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.311829", "ticker_sentiment_score": "-0.4428", "ticker_sentiment_label": "Bearish"}, {"ticker": "EBS", "relevance_score": "0.261959", "ticker_sentiment_score": "-0.160071", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JNJ", "relevance_score": "0.05333", "ticker_sentiment_score": "-0.554367", "ticker_sentiment_label": "Bearish"}]}, {"title": "66 Biggest Movers From Friday", "url": "https://www.benzinga.com/news/22/05/27341379/66-biggest-movers-from-friday", "time_published": "20220523T075758", "authors": ["Lisa Levin"], "summary": "Gainers GeoVax Labs, Inc. ( NASDAQ: GOVX ) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year. Leju Holdings Limited ( NYSE: LEJU ) shares jumped 53.4% to close at $4.85 on Friday. SIGA Technologies, Inc. ( NASDAQ: SIG", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/23/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.99737"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.04121, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DE", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.000467", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGC", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.001785", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002699", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002726", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.081635", "ticker_sentiment_score": "0.003282", "ticker_sentiment_label": "Neutral"}, {"ticker": "LITM", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.201757", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SIGA", "relevance_score": "0.081635", "ticker_sentiment_score": "0.072853", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.000208", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.054477", "ticker_sentiment_score": "0.001886", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.000386", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.081635", "ticker_sentiment_score": "-0.090646", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.077138", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.054477", "ticker_sentiment_score": "0.00371", "ticker_sentiment_label": "Neutral"}, {"ticker": "JWN", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.016167", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.081635", "ticker_sentiment_score": "0.036341", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBT", "relevance_score": "0.054477", "ticker_sentiment_score": "0.011199", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.054477", "ticker_sentiment_score": "0.006625", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.081635", "ticker_sentiment_score": "0.007477", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNYA", "relevance_score": "0.081635", "ticker_sentiment_score": "0.008831", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEJU", "relevance_score": "0.054477", "ticker_sentiment_score": "0.006051", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEDU", "relevance_score": "0.054477", "ticker_sentiment_score": "0.001617", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.091931", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.054477", "ticker_sentiment_score": "0.00512", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002313", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.081635", "ticker_sentiment_score": "0.033094", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTX", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.674532", "ticker_sentiment_label": "Bearish"}, {"ticker": "EQOS", "relevance_score": "0.081635", "ticker_sentiment_score": "0.006132", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLPT", "relevance_score": "0.081635", "ticker_sentiment_score": "0.030315", "ticker_sentiment_label": "Neutral"}, {"ticker": "DECK", "relevance_score": "0.054477", "ticker_sentiment_score": "0.072434", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.054477", "ticker_sentiment_score": "0.006588", "ticker_sentiment_label": "Neutral"}, {"ticker": "VS", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002585", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.054477", "ticker_sentiment_score": "0.004053", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.009305", "ticker_sentiment_label": "Neutral"}, {"ticker": "BJ", "relevance_score": "0.081635", "ticker_sentiment_score": "0.070249", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTC", "relevance_score": "0.081635", "ticker_sentiment_score": "0.01795", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.027254", "ticker_sentiment_score": "-0.000684", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOMZ", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.179773", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DTSS", "relevance_score": "0.081635", "ticker_sentiment_score": "-0.045237", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTG", "relevance_score": "0.054477", "ticker_sentiment_score": "0.008614", "ticker_sentiment_label": "Neutral"}, {"ticker": "BORR", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.02404", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTS", "relevance_score": "0.054477", "ticker_sentiment_score": "0.006469", "ticker_sentiment_label": "Neutral"}, {"ticker": "BURL", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.36248", "ticker_sentiment_label": "Bearish"}, {"ticker": "INDP", "relevance_score": "0.081635", "ticker_sentiment_score": "0.005792", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.081635", "ticker_sentiment_score": "0.002553", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.054477", "ticker_sentiment_score": "0.003417", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.027254", "ticker_sentiment_score": "0.033094", "ticker_sentiment_label": "Neutral"}, {"ticker": "SJ", "relevance_score": "0.054477", "ticker_sentiment_score": "0.000439", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.054477", "ticker_sentiment_score": "0.01758", "ticker_sentiment_label": "Neutral"}, {"ticker": "NURO", "relevance_score": "0.081635", "ticker_sentiment_score": "0.01095", "ticker_sentiment_label": "Neutral"}, {"ticker": "XCUR", "relevance_score": "0.081635", "ticker_sentiment_score": "0.001106", "ticker_sentiment_label": "Neutral"}, {"ticker": "DERM", "relevance_score": "0.054477", "ticker_sentiment_score": "0.003793", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXH", "relevance_score": "0.054477", "ticker_sentiment_score": "0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHTX", "relevance_score": "0.081635", "ticker_sentiment_score": "0.007777", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.081635", "ticker_sentiment_score": "0.000162", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSS", "relevance_score": "0.054477", "ticker_sentiment_score": "-0.065782", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.054477", "ticker_sentiment_score": "0.096204", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.054477", "ticker_sentiment_score": "0.002693", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELZ", "relevance_score": "0.081635", "ticker_sentiment_score": "0.001294", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRN", "relevance_score": "0.081635", "ticker_sentiment_score": "-0.009305", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROST", "relevance_score": "0.081635", "ticker_sentiment_score": "-0.451973", "ticker_sentiment_label": "Bearish"}, {"ticker": "APLD", "relevance_score": "0.054477", "ticker_sentiment_score": "0.00128", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVET", "relevance_score": "0.081635", "ticker_sentiment_score": "0.002682", "ticker_sentiment_label": "Neutral"}]}, {"title": "6 Stocks To Watch Amid Monkeypox Outbreak", "url": "https://www.benzinga.com/news/22/05/27334070/6-stocks-to-watch-amid-monkeypox-outbreak", "time_published": "20220520T210817", "authors": ["AJ Fabino"], "summary": "A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts. What's going on? Monkeypox, a relative to smallpox, is a rare disease thought to be limited to two regions in Africa and has two main types: the Central Afric", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/20/lab.trust-tru-katsande-6q5qg8iigro-unsplash.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.027176, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TNXP", "relevance_score": "0.142904", "ticker_sentiment_score": "0.000705", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.142904", "ticker_sentiment_score": "0.001162", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.212923", "ticker_sentiment_score": "0.011142", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVNRY", "relevance_score": "0.071741", "ticker_sentiment_score": "0.000703", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.142904", "ticker_sentiment_score": "0.000326", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVNKF", "relevance_score": "0.071741", "ticker_sentiment_score": "0.000703", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.281261", "ticker_sentiment_score": "0.011176", "ticker_sentiment_label": "Neutral"}]}, {"title": "38 Stocks Moving In Friday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/05/27327237/38-stocks-moving-in-fridays-mid-day-session", "time_published": "20220520T160330", "authors": ["Lisa Levin"], "summary": "Gainers Leju Holdings Limited ( NYSE: LEJU ) surged 27.8% to $4.0413. TherapeuticsMD, Inc. ( NASDAQ: TXMD ) shares jumped 25.6% to $2.85 after the company announced that it has received FDA approval of its supplemental New Drug Application for ANNOVERA. Eve Holding, Inc. ( NYSE: EVEX ) shar", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/20/mid-day_movers_image.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.990893"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.043243, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DE", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.002064", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.01011", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.098984", "ticker_sentiment_score": "0.001396", "ticker_sentiment_label": "Neutral"}, {"ticker": "BJ", "relevance_score": "0.148", "ticker_sentiment_score": "0.044174", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTSS", "relevance_score": "0.148", "ticker_sentiment_score": "-0.023699", "ticker_sentiment_label": "Neutral"}, {"ticker": "BORR", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.003735", "ticker_sentiment_label": "Neutral"}, {"ticker": "BURL", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.331996", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INDP", "relevance_score": "0.196451", "ticker_sentiment_score": "0.003394", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.148", "ticker_sentiment_score": "0.029956", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.049588", "ticker_sentiment_score": "0.012791", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.001406", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.098984", "ticker_sentiment_score": "0.000264", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.001915", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.098984", "ticker_sentiment_score": "0.000475", "ticker_sentiment_label": "Neutral"}, {"ticker": "JWN", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.00318", "ticker_sentiment_label": "Neutral"}, {"ticker": "NURO", "relevance_score": "0.148", "ticker_sentiment_score": "0.009456", "ticker_sentiment_label": "Neutral"}, {"ticker": "XCUR", "relevance_score": "0.148", "ticker_sentiment_score": "0.000223", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXH", "relevance_score": "0.098984", "ticker_sentiment_score": "0.001318", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBT", "relevance_score": "0.098984", "ticker_sentiment_score": "0.00259", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.148", "ticker_sentiment_score": "-0.003805", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHTX", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.000926", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEJU", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.000271", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSS", "relevance_score": "0.098984", "ticker_sentiment_score": "-0.045798", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.098984", "ticker_sentiment_score": "0.000486", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.148", "ticker_sentiment_score": "0.012791", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLPT", "relevance_score": "0.148", "ticker_sentiment_score": "0.00932", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRN", "relevance_score": "0.148", "ticker_sentiment_score": "-0.01011", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCM", "relevance_score": "0.098984", "ticker_sentiment_score": "0.000846", "ticker_sentiment_label": "Neutral"}, {"ticker": "DECK", "relevance_score": "0.098984", "ticker_sentiment_score": "0.046185", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROST", "relevance_score": "0.148", "ticker_sentiment_score": "-0.465182", "ticker_sentiment_label": "Bearish"}, {"ticker": "TXMD", "relevance_score": "0.098984", "ticker_sentiment_score": "1.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVET", "relevance_score": "0.148", "ticker_sentiment_score": "0.001803", "ticker_sentiment_label": "Neutral"}]}, {"title": "Monkeypox Fears Drive Smallpox Antiviral Makers Higher", "url": "https://www.zacks.com/stock/news/1927070/monkeypox-fears-drive-smallpox-antiviral-makers-higher", "time_published": "20220520T123800", "authors": ["Zacks Investment Research"], "summary": "Emergent BioSolutions (EBS) stock was up almost 12% while SIGA Technologies (SIGA) rose 17.1% on Thursday.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.041929, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SIGA", "relevance_score": "0.607476", "ticker_sentiment_score": "-0.060815", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.193001", "ticker_sentiment_score": "0.013577", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.458634", "ticker_sentiment_score": "-0.098111", "ticker_sentiment_label": "Neutral"}]}, {"title": "71 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/05/27318002/71-biggest-movers-from-yesterday", "time_published": "20220520T082731", "authors": ["Lisa Levin"], "summary": "Gainers NeuroMetrix, Inc. ( NASDAQ: NURO ) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia. VivoPower International PLC ( NASDAQ:", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/20/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.013704, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEGY", "relevance_score": "0.055946", "ticker_sentiment_score": "0.021826", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.055946", "ticker_sentiment_score": "0.003154", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYAD", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001977", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.02799", "ticker_sentiment_score": "0.012444", "ticker_sentiment_label": "Neutral"}, {"ticker": "UA", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.066954", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBWI", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002431", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNOX", "relevance_score": "0.055946", "ticker_sentiment_score": "0.023839", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIEW", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001115", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPOP", "relevance_score": "0.055946", "ticker_sentiment_score": "0.011712", "ticker_sentiment_label": "Neutral"}, {"ticker": "LITM", "relevance_score": "0.055946", "ticker_sentiment_score": "0.067598", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.055946", "ticker_sentiment_score": "0.010507", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDS", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.152492", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BILL", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002847", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.308477", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NOVN", "relevance_score": "0.083833", "ticker_sentiment_score": "0.004658", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.055946", "ticker_sentiment_score": "0.009302", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.055946", "ticker_sentiment_score": "0.008796", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOG", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.047485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.055946", "ticker_sentiment_score": "0.006289", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNYA", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002289", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.02799", "ticker_sentiment_score": "-0.066954", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRTS", "relevance_score": "0.055946", "ticker_sentiment_score": "0.000804", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLLS", "relevance_score": "0.055946", "ticker_sentiment_score": "0.006819", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.083833", "ticker_sentiment_score": "0.044934", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.055946", "ticker_sentiment_score": "0.011779", "ticker_sentiment_label": "Neutral"}, {"ticker": "SXTC", "relevance_score": "0.083833", "ticker_sentiment_score": "0.012444", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGI", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.287624", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SNPS", "relevance_score": "0.055946", "ticker_sentiment_score": "0.024499", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNRO", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001917", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEAL", "relevance_score": "0.055946", "ticker_sentiment_score": "0.080252", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIG", "relevance_score": "0.055946", "ticker_sentiment_score": "0.00781", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.055946", "ticker_sentiment_score": "0.030687", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.104888", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFI", "relevance_score": "0.083833", "ticker_sentiment_score": "0.009987", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.055946", "ticker_sentiment_score": "0.004885", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDNY", "relevance_score": "0.055946", "ticker_sentiment_score": "0.003658", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGEN", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.018968", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTC", "relevance_score": "0.083833", "ticker_sentiment_score": "0.026282", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.02799", "ticker_sentiment_score": "0.000584", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFH", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002076", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRX", "relevance_score": "0.055946", "ticker_sentiment_score": "-0.012885", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDP", "relevance_score": "0.083833", "ticker_sentiment_score": "0.004275", "ticker_sentiment_label": "Neutral"}, {"ticker": "SG", "relevance_score": "0.055946", "ticker_sentiment_score": "0.006098", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.055946", "ticker_sentiment_score": "0.008839", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.055946", "ticker_sentiment_score": "0.006237", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.083833", "ticker_sentiment_score": "0.035774", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.055946", "ticker_sentiment_score": "0.007085", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUUD", "relevance_score": "0.055946", "ticker_sentiment_score": "-0.003374", "ticker_sentiment_label": "Neutral"}, {"ticker": "NURO", "relevance_score": "0.055946", "ticker_sentiment_score": "0.015032", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAF", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001238", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.055946", "ticker_sentiment_score": "0.000475", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAC", "relevance_score": "0.083833", "ticker_sentiment_score": "0.003082", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.006915", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNFR", "relevance_score": "0.055946", "ticker_sentiment_score": "-0.034219", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001914", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVPR", "relevance_score": "0.055946", "ticker_sentiment_score": "0.005911", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAB", "relevance_score": "0.055946", "ticker_sentiment_score": "0.000383", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.055946", "ticker_sentiment_score": "0.003369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.083833", "ticker_sentiment_score": "0.003382", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRA", "relevance_score": "0.055946", "ticker_sentiment_score": "0.000614", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002359", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRKA", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002531", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.083833", "ticker_sentiment_score": "0.006608", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLD", "relevance_score": "0.055946", "ticker_sentiment_score": "0.002653", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRX", "relevance_score": "0.083833", "ticker_sentiment_score": "-0.024318", "ticker_sentiment_label": "Neutral"}, {"ticker": "APCX", "relevance_score": "0.055946", "ticker_sentiment_score": "0.001122", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.02799", "ticker_sentiment_score": "0.023839", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates", "url": "https://www.zacks.com/stock/news/1926061/biotech-stock-roundup-bbio-up-on-bmy-deal-gild-cmrx-offer-updates", "time_published": "20220518T154100", "authors": ["Zacks Investment Research"], "summary": "Regulatory updates and acquisition news from Bristol Myers' (BMY) and BridgeBio Pharma (BBIO) are a few key highlights from the biotech sector during the past week.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.007955, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BBIO", "relevance_score": "0.107351", "ticker_sentiment_score": "0.026429", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.107351", "ticker_sentiment_score": "0.008317", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.107351", "ticker_sentiment_score": "-0.011611", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.264171", "ticker_sentiment_score": "-0.001062", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.107351", "ticker_sentiment_score": "-0.001332", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix to Present at H.C. Wainwright Global Investment Conference", "url": "https://www.benzinga.com/pressreleases/22/05/g27264929/chimerix-to-present-at-h-c-wainwright-global-investment-conference", "time_published": "20220517T201500", "authors": ["Globe Newswire"], "summary": "DURHAM, N.C., May 17, 2022 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, Chief Executive Officer, will pr", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.01816, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.737923", "ticker_sentiment_score": "0.058627", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix to Present at H.C. Wainwright Global Investment Conference", "url": "https://www.globenewswire.com/news-release/2022/05/17/2445466/25619/en/Chimerix-to-Present-at-H-C-Wainwright-Global-Investment-Conference.html", "time_published": "20220517T201500", "authors": ["Chimerix", "Inc."], "summary": "DURHAM, N.C., May 17, 2022 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, Chief Executive Officer, will pr", "banner_image": "https://ml.globenewswire.com/Resource/Download/9b5bc625-104d-4a8b-9efc-877699d633d4?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.068747, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.493128", "ticker_sentiment_score": "0.068747", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Tuesday", "url": "https://www.benzinga.com/markets/options/22/05/27256852/52-weeks-high-and-low-article", "time_published": "20220517T153602", "authors": ["Benzinga Insights"], "summary": "On Tuesday, 123 stocks made new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was TJX Companies ( NYSE:TJX ) . The smallest company in terms of market cap to set a new 52-week low was NexGel ( NASDAQ:NXGL ) . AutoWeb ( NASDAQ", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8804.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.002686, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VINC", "relevance_score": "0.041198", "ticker_sentiment_score": "0.008261", "ticker_sentiment_label": "Neutral"}, {"ticker": "GIFI", "relevance_score": "0.041198", "ticker_sentiment_score": "0.001568", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALR", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.003233", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZFD", "relevance_score": "0.041198", "ticker_sentiment_score": "0.009453", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEPG", "relevance_score": "0.041198", "ticker_sentiment_score": "0.00653", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXGL", "relevance_score": "0.082287", "ticker_sentiment_score": "0.016304", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLAP", "relevance_score": "0.041198", "ticker_sentiment_score": "0.006133", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.041198", "ticker_sentiment_score": "0.005371", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.020606", "ticker_sentiment_score": "-0.001954", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBD", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.057425", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.041198", "ticker_sentiment_score": "0.028239", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBFS", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.001954", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEIP", "relevance_score": "0.041198", "ticker_sentiment_score": "0.000527", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.020606", "ticker_sentiment_score": "-0.021763", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYS", "relevance_score": "0.041198", "ticker_sentiment_score": "0.009222", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBRX", "relevance_score": "0.041198", "ticker_sentiment_score": "0.017409", "ticker_sentiment_label": "Neutral"}, {"ticker": "TJX", "relevance_score": "0.082287", "ticker_sentiment_score": "0.020499", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBOX", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.008063", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.020606", "ticker_sentiment_score": "-0.014567", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.041198", "ticker_sentiment_score": "0.005871", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGS", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.004997", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.041198", "ticker_sentiment_score": "0.009442", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.017239", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTO", "relevance_score": "0.061763", "ticker_sentiment_score": "-0.007816", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTTA", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.003697", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSIT", "relevance_score": "0.041198", "ticker_sentiment_score": "0.035354", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRE", "relevance_score": "0.041198", "ticker_sentiment_score": "0.02852", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVER", "relevance_score": "0.041198", "ticker_sentiment_score": "0.043934", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBX", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.039455", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRCT", "relevance_score": "0.041198", "ticker_sentiment_score": "0.037254", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.223678", "ticker_sentiment_score": "0.08492", "ticker_sentiment_label": "Neutral"}, {"ticker": "POAI", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.002551", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.041198", "ticker_sentiment_score": "0.001726", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.041198", "ticker_sentiment_score": "0.012485", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.020606", "ticker_sentiment_score": "0.00159", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.01287", "ticker_sentiment_label": "Neutral"}, {"ticker": "LANC", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.001884", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.002735", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCR", "relevance_score": "0.020606", "ticker_sentiment_score": "-0.010974", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.061763", "ticker_sentiment_score": "-0.004355", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOXX", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.224956", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BPTS", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.002897", "ticker_sentiment_label": "Neutral"}, {"ticker": "BURL", "relevance_score": "0.041198", "ticker_sentiment_score": "0.001502", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYEL", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.001782", "ticker_sentiment_label": "Neutral"}, {"ticker": "SJ", "relevance_score": "0.041198", "ticker_sentiment_score": "0.004746", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTCR", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.005433", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUUD", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.028859", "ticker_sentiment_label": "Neutral"}, {"ticker": "WW", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.006652", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.013567", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDGS", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.008605", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASNS", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.008791", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLT", "relevance_score": "0.041198", "ticker_sentiment_score": "0.008897", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.041198", "ticker_sentiment_score": "0.041835", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRS", "relevance_score": "0.041198", "ticker_sentiment_score": "0.009532", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTX", "relevance_score": "0.041198", "ticker_sentiment_score": "0.025822", "ticker_sentiment_label": "Neutral"}, {"ticker": "RUBY", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.000896", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDY", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.398253", "ticker_sentiment_label": "Bearish"}, {"ticker": "TNON", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.016386", "ticker_sentiment_label": "Neutral"}, {"ticker": "WGO", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.000141", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.041198", "ticker_sentiment_score": "0.008331", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.041198", "ticker_sentiment_score": "-0.005608", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( CMRX )  Plunges on Unfavorable Pipeline Updates", "url": "https://www.zacks.com/stock/news/1925354/chimerix-cmrx-plunges-on-unfavorable-pipeline-updates", "time_published": "20220517T130800", "authors": ["Zacks Investment Research"], "summary": "The development of Chimerix's (CMRX) lead candidate, ONC201, gets delayed as the FDA states that data from the retrospective study is unlikely to support an approval. The company ends the DSTAT program.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/88/898.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": -0.079173, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SESN", "relevance_score": "0.288468", "ticker_sentiment_score": "-0.168924", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALKS", "relevance_score": "0.356098", "ticker_sentiment_score": "-0.014354", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.690822", "ticker_sentiment_score": "-0.046661", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.146692", "ticker_sentiment_score": "0.002731", "ticker_sentiment_label": "Neutral"}]}, {"title": "73 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/05/27243846/73-biggest-movers-from-yesterday", "time_published": "20220517T084925", "authors": ["Lisa Levin"], "summary": "Gainers AgriFORCE Growing Systems Ltd. ( NASDAQ: AGRI ) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday. NewAge, Inc. ( NASDAQ: NBEV ) gained 65.8% to settle at $0.4245. Data Storage Corporation ( NASDAQ: DTST ) shares climbed 50% to close at $3.45 on Monday", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/16/yesterdays_movers_0.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.999896"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.021711, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CABA", "relevance_score": "0.052564", "ticker_sentiment_score": "0.008974", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.052564", "ticker_sentiment_score": "0.001927", "ticker_sentiment_label": "Neutral"}, {"ticker": "PT", "relevance_score": "0.052564", "ticker_sentiment_score": "0.002102", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNDL", "relevance_score": "0.052564", "ticker_sentiment_score": "0.009408", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.078775", "ticker_sentiment_score": "0.001378", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.052564", "ticker_sentiment_score": "0.006946", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.026296", "ticker_sentiment_score": "-0.049453", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.078775", "ticker_sentiment_score": "0.001565", "ticker_sentiment_label": "Neutral"}, {"ticker": "INNV", "relevance_score": "0.078775", "ticker_sentiment_score": "0.005589", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.026296", "ticker_sentiment_score": "0.006973", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNK", "relevance_score": "0.052564", "ticker_sentiment_score": "0.020134", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.006637", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANG", "relevance_score": "0.052564", "ticker_sentiment_score": "0.01189", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.052564", "ticker_sentiment_score": "0.005594", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.078775", "ticker_sentiment_score": "0.007535", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.130912", "ticker_sentiment_score": "-0.003956", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.052564", "ticker_sentiment_score": "-0.003223", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBX", "relevance_score": "0.078775", "ticker_sentiment_score": "0.014608", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.078775", "ticker_sentiment_score": "0.041955", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.052564", "ticker_sentiment_score": "0.001932", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.056519", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.078775", "ticker_sentiment_score": "0.018063", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.052564", "ticker_sentiment_score": "0.053273", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.052564", "ticker_sentiment_score": "0.024061", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.108366", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.052564", "ticker_sentiment_score": "-0.026197", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.078775", "ticker_sentiment_score": "8.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.003901", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERB", "relevance_score": "0.052564", "ticker_sentiment_score": "0.001695", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRE", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.021201", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARV", "relevance_score": "0.052564", "ticker_sentiment_score": "0.006973", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.052564", "ticker_sentiment_score": "-0.003901", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.052564", "ticker_sentiment_score": "0.005318", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.052564", "ticker_sentiment_score": "0.000861", "ticker_sentiment_label": "Neutral"}, {"ticker": "POAI", "relevance_score": "0.052564", "ticker_sentiment_score": "-0.020706", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEZS", "relevance_score": "0.052564", "ticker_sentiment_score": "-1.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUMA", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.020897", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.079313", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.078775", "ticker_sentiment_score": "0.064093", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.026296", "ticker_sentiment_score": "0.018063", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.052564", "ticker_sentiment_score": "-0.0039", "ticker_sentiment_label": "Neutral"}, {"ticker": "XERS", "relevance_score": "0.052564", "ticker_sentiment_score": "-0.026366", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEPH", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.389729", "ticker_sentiment_label": "Bearish"}, {"ticker": "DTSS", "relevance_score": "0.052564", "ticker_sentiment_score": "-0.126071", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKDA", "relevance_score": "0.078775", "ticker_sentiment_score": "0.027022", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.052564", "ticker_sentiment_score": "0.037344", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYX", "relevance_score": "0.052564", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLT", "relevance_score": "0.052564", "ticker_sentiment_score": "0.000673", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.008289", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.052564", "ticker_sentiment_score": "-0.000598", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.049453", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.052564", "ticker_sentiment_score": "0.024061", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMD", "relevance_score": "0.078775", "ticker_sentiment_score": "0.137654", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.052564", "ticker_sentiment_score": "-0.046015", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVE", "relevance_score": "0.052564", "ticker_sentiment_score": "0.009973", "ticker_sentiment_label": "Neutral"}, {"ticker": "CXDO", "relevance_score": "0.078775", "ticker_sentiment_score": "0.011295", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.052564", "ticker_sentiment_score": "0.003419", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBP", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.012886", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNHC", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.687094", "ticker_sentiment_label": "Bearish"}, {"ticker": "ASNS", "relevance_score": "0.052564", "ticker_sentiment_score": "0.001884", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTEC", "relevance_score": "0.078775", "ticker_sentiment_score": "0.014205", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.007197", "ticker_sentiment_label": "Neutral"}, {"ticker": "RTLR", "relevance_score": "0.078775", "ticker_sentiment_score": "0.01189", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIBT", "relevance_score": "0.052564", "ticker_sentiment_score": "0.004305", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIGL", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.001189", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHIL", "relevance_score": "0.052564", "ticker_sentiment_score": "0.05966", "ticker_sentiment_label": "Neutral"}, {"ticker": "UONE", "relevance_score": "0.052564", "ticker_sentiment_score": "0.006809", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.009288", "ticker_sentiment_label": "Neutral"}, {"ticker": "TK", "relevance_score": "0.026296", "ticker_sentiment_score": "0.020134", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLD", "relevance_score": "0.078775", "ticker_sentiment_score": "-0.009859", "ticker_sentiment_label": "Neutral"}, {"ticker": "MANT", "relevance_score": "0.078775", "ticker_sentiment_score": "0.01702", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVR", "relevance_score": "0.078775", "ticker_sentiment_score": "0.039887", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.078775", "ticker_sentiment_score": "0.000715", "ticker_sentiment_label": "Neutral"}, {"ticker": "CREX", "relevance_score": "0.078775", "ticker_sentiment_score": "0.00309", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mid-Afternoon Market Update: Dow Jumps 300 Points; Crude Oil Rises Over 3%", "url": "https://www.benzinga.com/news/earnings/22/05/27232138/mid-afternoon-market-update-dow-jumps-300-points-crude-oil-rises-over-3", "time_published": "20220516T183449", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 300 points on Monday. The Dow traded up 0.96% to 32,505.29 while the NASDAQ fell 0.02% to 11,803.19. The S&P also rose, gaining, 0.53% to 4,045.31. Also check this: Executives Buy Around $1.6M Of 4 Penny St", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/16/mid-afternoon-market-update.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": -0.019677, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREN", "relevance_score": "0.17402", "ticker_sentiment_score": "-0.01078", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.17402", "ticker_sentiment_score": "-0.007265", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.258442", "ticker_sentiment_score": "0.109383", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.17402", "ticker_sentiment_score": "0.008619", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.17402", "ticker_sentiment_score": "-0.129405", "ticker_sentiment_label": "Neutral"}, {"ticker": "RTLR", "relevance_score": "0.339861", "ticker_sentiment_score": "0.027285", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.17402", "ticker_sentiment_score": "0.008619", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( CMRX )  Q1 2022 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2022/05/16/chimerix-cmrx-q1-2022-earnings-call-transcript/", "time_published": "20220516T180037", "authors": ["Motley Fool Transcribing"], "summary": "CMRX earnings call for the period ending March 31, 2022.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}], "overall_sentiment_score": 0.318901, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.049602", "ticker_sentiment_score": "0.388882", "ticker_sentiment_label": "Bullish"}, {"ticker": "EBS", "relevance_score": "0.014181", "ticker_sentiment_score": "0.769379", "ticker_sentiment_label": "Bullish"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/markets/options/22/05/27226401/52-weeks-high-and-low-article", "time_published": "20220516T175917", "authors": ["Benzinga Insights"], "summary": "On Monday, 198 companies reached new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: BlackRock ( NYSE:BLK ) was the largest firm by market cap to set a new 52-week low. The smallest company by market cap to set a new 52-week low was Vallon Pharmaceuticals ( NASDAQ:VLON ) . Chimerix (", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8697.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.023675, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AHI", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.003672", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.013075", "ticker_sentiment_score": "-0.009321", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.026147", "ticker_sentiment_score": "0.006389", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNC", "relevance_score": "0.026147", "ticker_sentiment_score": "0.000549", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTA", "relevance_score": "0.026147", "ticker_sentiment_score": "0.009344", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTRX", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.300091", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JOAN", "relevance_score": "0.026147", "ticker_sentiment_score": "0.006135", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.168708", "ticker_sentiment_score": "-0.006268", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRX", "relevance_score": "0.026147", "ticker_sentiment_score": "0.003474", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.026147", "ticker_sentiment_score": "0.006898", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBY", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.005872", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRMD", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.249573", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OCCI", "relevance_score": "0.026147", "ticker_sentiment_score": "0.001154", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.026147", "ticker_sentiment_score": "0.007955", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBMT", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.022374", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.00973", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.026147", "ticker_sentiment_score": "0.012978", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.039212", "ticker_sentiment_score": "-0.006743", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMT", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.09217", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.026147", "ticker_sentiment_score": "0.003156", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOFT", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.002781", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.026147", "ticker_sentiment_score": "0.020603", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.026147", "ticker_sentiment_score": "0.088231", "ticker_sentiment_label": "Neutral"}, {"ticker": "XGN", "relevance_score": "0.026147", "ticker_sentiment_score": "0.007233", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.168708", "ticker_sentiment_score": "0.006205", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRO", "relevance_score": "0.026147", "ticker_sentiment_score": "0.006187", "ticker_sentiment_label": "Neutral"}, {"ticker": "POAI", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.015639", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUMA", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.011926", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.026147", "ticker_sentiment_score": "0.002725", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.026147", "ticker_sentiment_score": "0.005169", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.013075", "ticker_sentiment_score": "-0.000679", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSRR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.000832", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBNC", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.008161", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCMG", "relevance_score": "0.026147", "ticker_sentiment_score": "0.002198", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.000763", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNUN", "relevance_score": "0.013075", "ticker_sentiment_score": "0.009538", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRGA", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.010208", "ticker_sentiment_label": "Neutral"}, {"ticker": "URGN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.023251", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPTX", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.035222", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.026147", "ticker_sentiment_score": "0.013076", "ticker_sentiment_label": "Neutral"}, {"ticker": "OVID", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.018354", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASNS", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.012814", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.026147", "ticker_sentiment_score": "0.007176", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTXAP", "relevance_score": "0.013075", "ticker_sentiment_score": "0.009734", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.002345", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRS", "relevance_score": "0.026147", "ticker_sentiment_score": "0.001397", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.007947", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETN", "relevance_score": "0.039212", "ticker_sentiment_score": "-0.001009", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVCO", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.110115", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.041244", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.010704", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCOM", "relevance_score": "0.026147", "ticker_sentiment_score": "0.009538", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSWL", "relevance_score": "0.026147", "ticker_sentiment_score": "0.027174", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.001853", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRMR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.082926", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.001819", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUD", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.010607", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.006686", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADV", "relevance_score": "0.026147", "ticker_sentiment_score": "0.026697", "ticker_sentiment_label": "Neutral"}, {"ticker": "TALS", "relevance_score": "0.026147", "ticker_sentiment_score": "0.01369", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVL", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.239551", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FORD", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004667", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCCO", "relevance_score": "0.026147", "ticker_sentiment_score": "0.012123", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.026147", "ticker_sentiment_score": "0.000196", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.22125", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HTLF", "relevance_score": "0.026147", "ticker_sentiment_score": "-5.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQ", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.015689", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.013075", "ticker_sentiment_score": "-0.22125", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IREN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.003521", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMS", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.000826", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.000183", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTTA", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.174483", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FFWM", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.00194", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEBR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.016929", "ticker_sentiment_label": "Neutral"}, {"ticker": "WASH", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004425", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.026147", "ticker_sentiment_score": "0.0051", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTX", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.005621", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.035642", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.170933", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UMPQ", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004235", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPH", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.009103", "ticker_sentiment_label": "Neutral"}, {"ticker": "OZK", "relevance_score": "0.026147", "ticker_sentiment_score": "0.002554", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSBW", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.021729", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBCP", "relevance_score": "0.026147", "ticker_sentiment_score": "0.007982", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.026147", "ticker_sentiment_score": "0.000709", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.078328", "ticker_sentiment_score": "0.005893", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFG", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004499", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFST", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.00093", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVLO", "relevance_score": "0.026147", "ticker_sentiment_score": "0.001081", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYEL", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.252577", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RYB", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.231046", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HRTG", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.011215", "ticker_sentiment_label": "Neutral"}, {"ticker": "USWS", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.043356", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.026147", "ticker_sentiment_score": "0.01074", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKH", "relevance_score": "0.013075", "ticker_sentiment_score": "0.013076", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.013075", "ticker_sentiment_score": "0.012978", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFBC", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.001377", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBNK", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004487", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATBP", "relevance_score": "0.013075", "ticker_sentiment_score": "-0.007585", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPB", "relevance_score": "0.026147", "ticker_sentiment_score": "0.00221", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.026147", "ticker_sentiment_score": "0.005918", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.013781", "ticker_sentiment_label": "Neutral"}]}, {"title": "12 Health Care Stocks Moving In Monday's Intraday Session", "url": "https://www.benzinga.com/trading-ideas/movers/22/05/27230053/12-health-care-stocks-moving-in-mondays-intraday-session", "time_published": "20220516T175801", "authors": ["Benzinga Insights"], "summary": "Gainers Harpoon Therapeutics ( NASDAQ:HARP ) shares increased by 38.0% to $2.76 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 1.1 million shares, making up 325.1% of its average full-day volume over the last 100 days. The market value of their outstandin", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8715.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.865346"}, {"topic": "Earnings", "relevance_score": "0.9973"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.004525, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BWV", "relevance_score": "0.124228", "ticker_sentiment_score": "0.000563", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.124228", "ticker_sentiment_score": "0.002971", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBP", "relevance_score": "0.124228", "ticker_sentiment_score": "0.005249", "ticker_sentiment_label": "Neutral"}, {"ticker": "POAI", "relevance_score": "0.124228", "ticker_sentiment_score": "0.01029", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.124228", "ticker_sentiment_score": "0.002908", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.124228", "ticker_sentiment_score": "0.0043", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.124228", "ticker_sentiment_score": "0.001626", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.124228", "ticker_sentiment_score": "0.003341", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.185401", "ticker_sentiment_score": "0.001443", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.124228", "ticker_sentiment_score": "-0.00024", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.124228", "ticker_sentiment_score": "0.002932", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.124228", "ticker_sentiment_score": "-0.001108", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mid-Day Market Update: Dow Edges Higher; Data Storage Shares Surge", "url": "https://www.benzinga.com/news/earnings/22/05/27228816/mid-day-market-update-dow-edges-higher-data-storage-shares-surge", "time_published": "20220516T165122", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 20 points on Monday. The Dow traded up 0.07% to 32,220.38 while the NASDAQ fell 0.58% to 11,736.63. The S&P also fell, dropping, 0.14% to 4,018.16. Also check this: Executives Buy Around $1.6M Of 4 Penny Stocks Leadin", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/16/mid-day-market-update.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": -0.014663, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREN", "relevance_score": "0.174713", "ticker_sentiment_score": "-0.007528", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.174713", "ticker_sentiment_score": "0.000194", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.259451", "ticker_sentiment_score": "0.123813", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.174713", "ticker_sentiment_score": "0.010599", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.174713", "ticker_sentiment_score": "-0.141204", "ticker_sentiment_label": "Neutral"}, {"ticker": "RTLR", "relevance_score": "0.34115", "ticker_sentiment_score": "0.027375", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.174713", "ticker_sentiment_score": "0.010599", "ticker_sentiment_label": "Neutral"}]}, {"title": "41 Stocks Moving In Monday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/05/27227706/41-stocks-moving-in-mondays-mid-day-session", "time_published": "20220516T161047", "authors": ["Lisa Levin"], "summary": "Gainers Data Storage Corporation ( NASDAQ: DTST ) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results. AgriFORCE Growing Systems Ltd. ( NASDAQ: AGRI ) rose 39% to $2.32 after gaining around 10% on Friday. Faraday Future Intelligent Electric Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/16/mid-day_movers_image.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.967645"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.01304, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PTE", "relevance_score": "0.141227", "ticker_sentiment_score": "0.002649", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONX", "relevance_score": "0.094427", "ticker_sentiment_score": "0.000259", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUMA", "relevance_score": "0.141227", "ticker_sentiment_score": "-0.025676", "ticker_sentiment_label": "Neutral"}, {"ticker": "PT", "relevance_score": "0.094427", "ticker_sentiment_score": "-0.000158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNDL", "relevance_score": "0.094427", "ticker_sentiment_score": "0.004294", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.141227", "ticker_sentiment_score": "0.017761", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.094427", "ticker_sentiment_score": "0.02686", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.094427", "ticker_sentiment_score": "0.001325", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.094427", "ticker_sentiment_score": "-0.001874", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEPH", "relevance_score": "0.141227", "ticker_sentiment_score": "-0.343602", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INNV", "relevance_score": "0.141227", "ticker_sentiment_score": "0.002659", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.047296", "ticker_sentiment_score": "0.000692", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNK", "relevance_score": "0.094427", "ticker_sentiment_score": "0.012519", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.094427", "ticker_sentiment_score": "0.007126", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANG", "relevance_score": "0.094427", "ticker_sentiment_score": "0.010417", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.094427", "ticker_sentiment_score": "0.007618", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.141227", "ticker_sentiment_score": "-0.02348", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMD", "relevance_score": "0.141227", "ticker_sentiment_score": "0.136818", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.094427", "ticker_sentiment_score": "-0.049998", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVE", "relevance_score": "0.094427", "ticker_sentiment_score": "0.005061", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRAX", "relevance_score": "0.094427", "ticker_sentiment_score": "0.000837", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.141227", "ticker_sentiment_score": "0.049514", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.094427", "ticker_sentiment_score": "0.001932", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.141227", "ticker_sentiment_score": "-0.073501", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.094427", "ticker_sentiment_score": "-0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.278063", "ticker_sentiment_score": "0.02686", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASNS", "relevance_score": "0.094427", "ticker_sentiment_score": "0.000422", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTEC", "relevance_score": "0.141227", "ticker_sentiment_score": "0.022052", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.141227", "ticker_sentiment_score": "0.016701", "ticker_sentiment_label": "Neutral"}, {"ticker": "RTLR", "relevance_score": "0.141227", "ticker_sentiment_score": "0.010417", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.094427", "ticker_sentiment_score": "0.007618", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.094427", "ticker_sentiment_score": "-0.007497", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.141227", "ticker_sentiment_score": "-0.013657", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHIL", "relevance_score": "0.094427", "ticker_sentiment_score": "0.026186", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.141227", "ticker_sentiment_score": "-0.021903", "ticker_sentiment_label": "Neutral"}, {"ticker": "TK", "relevance_score": "0.047296", "ticker_sentiment_score": "0.012519", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERB", "relevance_score": "0.094427", "ticker_sentiment_score": "0.000344", "ticker_sentiment_label": "Neutral"}, {"ticker": "MANT", "relevance_score": "0.141227", "ticker_sentiment_score": "0.00352", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFIE", "relevance_score": "0.094427", "ticker_sentiment_score": "-0.016384", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARV", "relevance_score": "0.094427", "ticker_sentiment_score": "0.000692", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANPC", "relevance_score": "0.094427", "ticker_sentiment_score": "0.004802", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why Chimerix Stock Is Imploding Today", "url": "https://www.fool.com/investing/2022/05/16/heres-why-chimerix-stock-is-imploding-today/", "time_published": "20220516T145934", "authors": ["Cory Renauer"], "summary": "Investors are furious about management's plan to sell its most valuable asset in order to chase a lackluster oncology program.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F680102%2Fscientists-looking-at-dna-on-screen-getty.jpg&w=700&op=resize", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": -0.391007, "overall_sentiment_label": "Bearish", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.752119", "ticker_sentiment_score": "-0.391007", "ticker_sentiment_label": "Bearish"}, {"ticker": "EBS", "relevance_score": "0.227325", "ticker_sentiment_score": "-0.327937", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Mid-Morning Market Update: Markets Open Lower; Dow Drops 70 Points", "url": "https://www.benzinga.com/news/earnings/22/05/27223381/mid-morning-market-update-markets-open-lower-dow-drops-70-points", "time_published": "20220516T142615", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded lower this morning, with the Nasdaq Composite adding more than 400 points on Friday. Following the market opening Monday, the Dow traded down 0.22% to 32,125.87 while the NASDAQ fell 0.23% to 11,777.64. The S&P also fell, dropping, 0.18% to 4,016.79. Also check this: Executives Bu", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/16/mid-morning-market-update.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": -0.028776, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREN", "relevance_score": "0.169318", "ticker_sentiment_score": "0.000822", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.169318", "ticker_sentiment_score": "0.000395", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.085143", "ticker_sentiment_score": "0.019958", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.169318", "ticker_sentiment_score": "0.008619", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.251594", "ticker_sentiment_score": "0.019958", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.169318", "ticker_sentiment_score": "-0.258001", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FFIE", "relevance_score": "0.169318", "ticker_sentiment_score": "0.021259", "ticker_sentiment_label": "Neutral"}, {"ticker": "RTLR", "relevance_score": "0.331098", "ticker_sentiment_score": "0.044402", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.169318", "ticker_sentiment_score": "0.008619", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Shares Plummet After Divesting Its Only Marketed Product For Over $300M", "url": "https://www.benzinga.com/general/biotech/22/05/27220874/chimerix-shares-plummet-after-divesting-its-only-marketed-product-for-over-300m", "time_published": "20220516T135412", "authors": ["Vandana Singh"], "summary": "Emergent BioSolutions Inc ( NYSE: EBS ) has agreed to acquire Chimerix Inc's ( NASDAQ: CMRX ) exclusive worldwide rights to Tembexa ( brincidofovir ) , the first FDA-approved antiviral for all age groups for smallpox. \"It exemplifies our thoughtful M&A strategy as part of our 2024 growth plan", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/16/aapharma_4.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.095375, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SYMQY", "relevance_score": "0.149842", "ticker_sentiment_score": "0.016097", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.655129", "ticker_sentiment_score": "0.018085", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.294446", "ticker_sentiment_score": "0.041228", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More", "url": "https://www.benzinga.com/general/biotech/22/05/27217168/the-week-ahead-in-biotech-may-16-21-gene-cell-therapy-conference-presentations-tapering-earnings-", "time_published": "20220516T133825", "authors": ["Shanthi Rexaline"], "summary": "Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from mid-cap companies. On the M&A front, Pfizer, Inc. ( NYSE: PFE ) announced a deal to buy migraine drugma", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/16/biotech10.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.039154, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDWD", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000231", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYRS", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABA", "relevance_score": "0.122362", "ticker_sentiment_score": "0.003657", "ticker_sentiment_label": "Neutral"}, {"ticker": "RARE", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000545", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVE", "relevance_score": "0.061362", "ticker_sentiment_score": "0.000285", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDNXF", "relevance_score": "0.061362", "ticker_sentiment_score": "0.057058", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.122362", "ticker_sentiment_score": "0.006818", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBX", "relevance_score": "0.122362", "ticker_sentiment_score": "0.041753", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGNX", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000882", "ticker_sentiment_label": "Neutral"}, {"ticker": "VBLT", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000231", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIFE", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000297", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHVN", "relevance_score": "0.122362", "ticker_sentiment_score": "0.006818", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNX", "relevance_score": "0.122362", "ticker_sentiment_score": "-0.000986", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.182644", "ticker_sentiment_score": "0.001984", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALA", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000182", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDAP", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000231", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.122362", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.122362", "ticker_sentiment_score": "-0.338121", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "JetBlue Goes Hostile on Spirit, but This Biopharma's Getting Hit Hard", "url": "https://www.fool.com/investing/2022/05/16/jetblue-goes-hostile-on-spirit-but-this-biopharmas/", "time_published": "20220516T131144", "authors": ["Dan Caplinger"], "summary": "The market looked prepared for a quiet open on Monday.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F680097%2Fairplane-couple-2022-gettyimages-1124800299.jpg&w=700&op=resize", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.576289"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.019443, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ULCC", "relevance_score": "0.065613", "ticker_sentiment_score": "-0.023466", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBLU", "relevance_score": "0.130784", "ticker_sentiment_score": "0.061579", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVE", "relevance_score": "0.195077", "ticker_sentiment_score": "0.015636", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.435581", "ticker_sentiment_score": "0.036255", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.195077", "ticker_sentiment_score": "0.070248", "ticker_sentiment_label": "Neutral"}]}, {"title": "12 Health Care Stocks Moving In Monday's Pre-Market Session", "url": "https://www.benzinga.com/trading-ideas/movers/22/05/27217184/12-health-care-stocks-moving-in-mondays-pre-market-session", "time_published": "20220516T121648", "authors": ["Benzinga Insights"], "summary": "Gainers Athenex ( NASDAQ:ATNX ) shares increased by 30.5% to $0.62 during Monday's pre-market session. The market value of their outstanding shares is at $69.1 million. As per the press release, Q1 earnings came out 4 days ago. Verastem ( NASDAQ:VSTM ) stock rose 25.0% to $1.35. The company's ma", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8664.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.005967, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATNX", "relevance_score": "0.237551", "ticker_sentiment_score": "0.007507", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.237551", "ticker_sentiment_score": "0.003548", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.237551", "ticker_sentiment_score": "0.00191", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.237551", "ticker_sentiment_score": "0.000519", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDTX", "relevance_score": "0.237551", "ticker_sentiment_score": "0.022496", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.237551", "ticker_sentiment_score": "-0.000395", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.237551", "ticker_sentiment_score": "0.002454", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.237551", "ticker_sentiment_score": "0.003241", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSTM", "relevance_score": "0.237551", "ticker_sentiment_score": "0.008247", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.237551", "ticker_sentiment_score": "0.007559", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRGA", "relevance_score": "0.237551", "ticker_sentiment_score": "0.009778", "ticker_sentiment_label": "Neutral"}]}, {"title": "Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA\u00ae  ( brincidofovir ) , the First FDA-Approved Smallpox Oral Antiviral for All Ages", "url": "https://www.benzinga.com/pressreleases/22/05/g27214216/emergent-biosolutions-to-acquire-from-chimerix-its-exclusive-worldwide-rights-to-tembexa-brincidof", "time_published": "20220516T103217", "authors": ["Globe Newswire"], "summary": "Expands and further diversifies Emergent's medical countermeasures portfolio with the addition of a small molecule therapeutic addressing a high priority public health threat Transaction to be funded with currently available funds; Expected to be accretive beginning with anticipated product deliveri", "banner_image": "", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.121534, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SYMQY", "relevance_score": "0.026207", "ticker_sentiment_score": "0.001206", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.207305", "ticker_sentiment_score": "0.113192", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.078508", "ticker_sentiment_score": "0.201149", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA\u00ae  ( brincidofovir ) , the First FDA-Approved Smallpox Oral Antiviral for All Ages", "url": "https://www.globenewswire.com/news-release/2022/05/16/2443624/33240/en/Emergent-BioSolutions-to-Acquire-from-Chimerix-its-Exclusive-Worldwide-Rights-to-TEMBEXA-brincidofovir-the-First-FDA-Approved-Smallpox-Oral-Antiviral-for-All-Ages.html", "time_published": "20220516T103200", "authors": ["Inc.", "Emergent Biosolutions"], "summary": "GAITHERSBURG, Md., May 16, 2022 ( GLOBE NEWSWIRE ) -- Emergent BioSolutions Inc. ( NYSE: EBS ) announced today that it has entered into a definitive agreement with Chimerix, Inc. ( NASDAQ: CMRX ) , to acquire Chimerix's exclusive worldwide rights to TEMBEXA\u00ae ( brincidofovir ) , the first an", "banner_image": "https://ml.globenewswire.com/Resource/Download/56a9097d-af91-4bcf-8c42-5905e1614ef1?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.029393, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SYMQY", "relevance_score": "0.027379", "ticker_sentiment_score": "0.004035", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.216352", "ticker_sentiment_score": "0.010192", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.054725", "ticker_sentiment_score": "0.023036", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties", "url": "https://www.globenewswire.com/news-release/2022/05/16/2443619/25619/en/Chimerix-Announces-Sale-of-TEMBEXA-to-Emergent-BioSolutions-for-up-to-337-5-Million-plus-Royalties.html", "time_published": "20220516T103000", "authors": ["Chimerix", "Inc."], "summary": "- $225 Million in Upfront Proceeds Secures Substantial Capital to Fund Operations and Allows for Participation in Future Economics -", "banner_image": "https://ml.globenewswire.com/Resource/Download/9b5bc625-104d-4a8b-9efc-877699d633d4?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.058321, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SYMQY", "relevance_score": "0.041075", "ticker_sentiment_score": "0.008342", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.463442", "ticker_sentiment_score": "0.058321", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.041075", "ticker_sentiment_score": "0.125616", "ticker_sentiment_label": "Neutral"}]}, {"title": "Earnings Scheduled For May 16, 2022", "url": "https://www.benzinga.com/news/earnings/22/05/27212365/earnings-scheduled-for-may-16-2022", "time_published": "20220516T091844", "authors": ["Benzinga Insights"], "summary": "Companies Reporting Before The Bell \u2022 AcelRx Pharmaceuticals ( NASDAQ:ACRX ) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. \u2022 Synthetic Biologics ( AMEX:SYN ) is likely to report earnings for its first quarter. \u2022 Passage Bio ( NASDAQ:PASG ) is estimate", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/earnings_image_6576.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.043345, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SYRS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.11902", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOK", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.06406", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMPL", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.019337", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNDL", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.004947", "ticker_sentiment_label": "Neutral"}, {"ticker": "XSPA", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.025405", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKYI", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.013336", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZFD", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.035784", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.029444", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCTZF", "relevance_score": "0.016664", "ticker_sentiment_score": "-0.002442", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPW", "relevance_score": "0.033321", "ticker_sentiment_score": "0.000424", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.032928", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.052439", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.021462", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUOT", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.008653", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.025617", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVN", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.117586", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.033321", "ticker_sentiment_score": "0.001106", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBOX", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.057029", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.016243", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.014274", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRN", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.004201", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.013049", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.00091", "ticker_sentiment_label": "Neutral"}, {"ticker": "OEG", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.092846", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.018673", "ticker_sentiment_label": "Neutral"}, {"ticker": "REED", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.077589", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHPW", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.08186", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTK", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.078532", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.036838", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBX", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.080536", "ticker_sentiment_label": "Neutral"}, {"ticker": "GVP", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.03078", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSEM", "relevance_score": "0.033321", "ticker_sentiment_score": "0.00047", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVV", "relevance_score": "0.033321", "ticker_sentiment_score": "0.000374", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPK", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.003257", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.016664", "ticker_sentiment_score": "-0.094731", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.005089", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARKR", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.013015", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.011176", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONM", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.021251", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.003243", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.058816", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONQ", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.027739", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGTI", "relevance_score": "0.033321", "ticker_sentiment_score": "0.001067", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOHU", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.021159", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOXX", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.001561", "ticker_sentiment_label": "Neutral"}, {"ticker": "YALA", "relevance_score": "0.033321", "ticker_sentiment_score": "0.000273", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSIX", "relevance_score": "0.016664", "ticker_sentiment_score": "-0.013082", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRBY", "relevance_score": "0.033321", "ticker_sentiment_score": "0.005331", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSYS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.085798", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPWR", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.024293", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.082786", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCYG", "relevance_score": "0.033321", "ticker_sentiment_score": "0.001324", "ticker_sentiment_label": "Neutral"}, {"ticker": "VISL", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.010466", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUV", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.126028", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALA", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.102112", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYR", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.014322", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMTI", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.010307", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTEC", "relevance_score": "0.033321", "ticker_sentiment_score": "0.002028", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKT", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.152837", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PIK", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.019572", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPSI", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.013082", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.023918", "ticker_sentiment_label": "Neutral"}, {"ticker": "CREX", "relevance_score": "0.033321", "ticker_sentiment_score": "0.000929", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.041497", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDY", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.049092", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.035581", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.006916", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEV", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.052586", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUNW", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.146322", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVOS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.002955", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGLX", "relevance_score": "0.033321", "ticker_sentiment_score": "0.007317", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRGV", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.036256", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.017123", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.04072", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSN", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.08772", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYAOF", "relevance_score": "0.016664", "ticker_sentiment_score": "-0.301357", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSHA", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.0072", "ticker_sentiment_label": "Neutral"}, {"ticker": "DADA", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.185166", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OMQS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.025846", "ticker_sentiment_label": "Neutral"}, {"ticker": "VWE", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.008857", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALBO", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.079045", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCSI", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.008802", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTRU", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.01766", "ticker_sentiment_label": "Neutral"}, {"ticker": "IZEA", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.009453", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTO", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.061477", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANW", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.062127", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRXT", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.094731", "ticker_sentiment_label": "Neutral"}, {"ticker": "KORE", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.162509", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SGRP", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.027371", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRCL", "relevance_score": "0.033321", "ticker_sentiment_score": "0.005181", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEBR", "relevance_score": "0.033321", "ticker_sentiment_score": "0.000883", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.033321", "ticker_sentiment_score": "-5.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.033763", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.123196", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAR", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.180603", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TIVC", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.012546", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.00956", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.180541", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WIX", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.025827", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.00073", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.016664", "ticker_sentiment_score": "-0.104614", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDV-P-A", "relevance_score": "0.016664", "ticker_sentiment_score": "-0.061234", "ticker_sentiment_label": "Neutral"}, {"ticker": "INPX", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.00928", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.000484", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNDY", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.174755", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RMTI", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.046915", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.042158", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWBR", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.065184", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAST", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.091787", "ticker_sentiment_label": "Neutral"}, {"ticker": "USWS", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.044332", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUNA", "relevance_score": "0.033321", "ticker_sentiment_score": "0.000697", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.0528", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.064231", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNGY", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.068993", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARK", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.007086", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.014692", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHIL", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.10898", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNA", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.167576", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "QRHC", "relevance_score": "0.033321", "ticker_sentiment_score": "0.000789", "ticker_sentiment_label": "Neutral"}, {"ticker": "REKR", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.04096", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIRO", "relevance_score": "0.033321", "ticker_sentiment_score": "-0.016424", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix to Participate in Maxim Group Panel Discussion", "url": "https://www.globenewswire.com/news-release/2022/05/12/2442513/25619/en/Chimerix-to-Participate-in-Maxim-Group-Panel-Discussion.html", "time_published": "20220512T201500", "authors": ["Chimerix", "Inc."], "summary": "DURHAM, N.C., May 12, 2022 ( GLOBE NEWSWIRE ) -- Chimerix ( NASDAQ:CMRX ) , a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Josh Allen, Ph.D., Chief Technology Officer of", "banner_image": "https://ml.globenewswire.com/Resource/Download/9b5bc625-104d-4a8b-9efc-877699d633d4?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.054397, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.374031", "ticker_sentiment_score": "0.054397", "ticker_sentiment_label": "Neutral"}]}, {"title": "Kineticos Life Sciences Announces Tom Pitler as President and Chief Operating Officer", "url": "https://www.prnewswire.com/news-releases/kineticos-life-sciences-announces-tom-pitler-as-president-and-chief-operating-officer-301545478.html", "time_published": "20220512T130000", "authors": ["Kineticos"], "summary": "Prior to joining Kineticos Life Sciences, Dr. Pitler ran an independent consulting practice, and prior to that was employed by Heron Therapeutics, VetMed Therapeutics, Capture Pharmaceuticals, Chimerix, Neurogen Corporation, and the University of Maryland School of Medicine.", "banner_image": "https://mma.prnewswire.com/media/1815658/Kineticos_Logo_Purple_Light_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.001401, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.096516", "ticker_sentiment_score": "0.001401", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.096516", "ticker_sentiment_score": "0.001401", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( NASDAQ:CMRX )  Downgraded by StockNews.com", "url": "https://decaymag.com/2022/04/20/chimerix-nasdaqcmrx-downgraded-by-stocknews-com.html", "time_published": "20220420T052243", "authors": ["admin"], "summary": "StockNews.com cut shares of Chimerix  ( NASDAQ:CMRX - Get Rating )  from a hold rating to a sell rating in a research note issued to investors on Saturday.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/chimerix-inc-logo.JPG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "decaymag.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.009822, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.075373", "ticker_sentiment_score": "0.017153", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.150075", "ticker_sentiment_score": "0.017153", "ticker_sentiment_label": "Neutral"}, {"ticker": "MET", "relevance_score": "0.150075", "ticker_sentiment_score": "0.017153", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.869903", "ticker_sentiment_score": "0.009822", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Downgrades Chimerix  ( NASDAQ:CMRX )  to Sell", "url": "https://www.defenseworld.net/2022/04/16/stocknews-com-downgrades-chimerix-nasdaqcmrx-to-sell.html", "time_published": "20220416T051441", "authors": ["admin"], "summary": "Chimerix  ( NASDAQ:CMRX - Get Rating )  was downgraded by StockNews.com from a \"hold\" rating to a \"sell\" rating in a note issued to investors on Saturday.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/chimerix-inc-logo.JPG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.00452, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.082705", "ticker_sentiment_score": "0.030093", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.164525", "ticker_sentiment_score": "0.006017", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.903382", "ticker_sentiment_score": "-0.00452", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More", "url": "https://www.benzinga.com/general/biotech/22/04/26630399/the-daily-biotech-pulse-pfizer-biontech-covid-19-booster-data-in-kids-regenerons-covid-19-therapy", "time_published": "20220414T133544", "authors": ["Vandana Singh"], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours:\nStocks In Focus\nPfizer-BioNTech's COVID-19 Vaccine Booster Shows High Immune Response In Kids Ages 5-11\nPfizer Inc  ( NYSE: PFE )  and BioNTech SE  ( NASDAQ: BNTX )  have announced results from a Phase 2/3 trial of a 1", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/04/14/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.000404, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRSN", "relevance_score": "0.08395", "ticker_sentiment_score": "-9.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCX", "relevance_score": "0.08395", "ticker_sentiment_score": "0.005503", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.08395", "ticker_sentiment_score": "-0.017789", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMAB", "relevance_score": "0.08395", "ticker_sentiment_score": "0.011626", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.08395", "ticker_sentiment_score": "0.011626", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMTX", "relevance_score": "0.08395", "ticker_sentiment_score": "0.009005", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRX", "relevance_score": "0.08395", "ticker_sentiment_score": "0.004269", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.125635", "ticker_sentiment_score": "0.01172", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.125635", "ticker_sentiment_score": "0.01172", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.08395", "ticker_sentiment_score": "0.007047", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVBXF", "relevance_score": "0.08395", "ticker_sentiment_score": "0.011255", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTGX", "relevance_score": "0.125635", "ticker_sentiment_score": "-0.015079", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.08395", "ticker_sentiment_score": "0.008517", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVI", "relevance_score": "0.08395", "ticker_sentiment_score": "0.00023", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMB", "relevance_score": "0.08395", "ticker_sentiment_score": "0.048468", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.125635", "ticker_sentiment_score": "0.043727", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix Confirms Ongoing Negotiations With BARDA On Smallpox Medicine Contract", "url": "https://www.benzinga.com/general/biotech/22/04/26631638/chimerix-confirms-ongoing-negotiations-with-barda-on-smallpox-medicine-contract", "time_published": "20220414T123147", "authors": ["Vandana Singh"], "summary": "In its SEC filing, Chimerix Inc  ( NASDAQ: CMRX )  announced that it had been aware of unusual trading activity in the Company's common stock. \nThe Company believes the unusual trading activity may be attributable to statements regarding smallpox antiviral development and procurement contained in th", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/04/14/aapharma_4.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": -0.033009, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRX", "relevance_score": "0.690822", "ticker_sentiment_score": "0.002445", "ticker_sentiment_label": "Neutral"}]}, {"title": "Chimerix  ( NASDAQ:CMRX )  Stock Rating Upgraded by StockNews.com", "url": "https://www.defenseworld.net/2022/04/12/chimerix-nasdaqcmrx-stock-rating-upgraded-by-stocknews-com.html", "time_published": "20220412T052041", "authors": ["admin"], "summary": "StockNews.com upgraded shares of Chimerix  ( NASDAQ:CMRX - Get Rating )  from a sell rating to a hold rating in a research note issued to investors on Friday.", "banner_image": "https://www.marketbeat.com/logos/chimerix-inc-logo.JPG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.015254, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYPL", "relevance_score": "0.081331", "ticker_sentiment_score": "0.048191", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.081331", "ticker_sentiment_score": "0.048191", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.161819", "ticker_sentiment_score": "0.013948", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.897692", "ticker_sentiment_score": "0.015254", "ticker_sentiment_label": "Neutral"}]}]}